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IV. Abstract  
 
 
The objective of this project was to design a pulsatile flow generator for the analysis of wave 
propagation in blood vessels for implementation in the early detection of arterial disease. Latex 
iliac artery models, varying in arterial compliance and degrees of stenosis, were studied ex vivo 
utilizing the system at 1 Hz (60bpm) to validate the systems physiological functional capabilities. 
Validation methods proved successful as the physiological models produced waveform variances 
with changes in arterial wall mechanical properties and morphology.   
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1. Introduction  
 
 
The American Heart Association has reported that 36.3% of deaths in the United States of 
America were caused by cardiovascular diseases. Cardiovascular diseases include high blood 
pressure, coronary heart disease, myocardial infarction, stroke, stenosis, and atherosclerosis. 
High blood pressure is considered the silent killer because there are no symptoms and the only 
way to check is to take your blood pressure. However if your blood pressure is not controlled it 
can lead to stroke, heart attack or heart failure. High blood pressure or hypertension is when 
systolic pressure is over or equal to 140 mmHg or diastolic pressure is equal or greater than 90 
mmHg. Some methods of regulating hypertension include diet and exercise. 
 
Coronary heart disease, the leader of deaths in America begins with the onset of atherosclerosis. 
Atherosclerosis occurs when fatty streaks form plaque; in the case of coronary heart disease the 
artery walls build up with atheromatous plaques. Blood clotting can occur once the atheromatous 
plaques rupture, impeding blood flow. Prevention of this disease involves the proper introduction 
of diet control and regular cardio exercise into ones lifestyle. 
 
Myocardial infarction happens when there is an interruption of blood supply to part of the heart. 
There is an increased risk for myocardial infarction in smokers, coronary heart disease patients, 
stroke victims, and those suffering from abnormalities in their heart rhythms. Symptoms include 
shortness of breath, chest pain, and palpitations. Immediate treatment consists of oxygen, aspirin, 
and pain relief. Long term treatment includes anticoagulants, dilation of flow or a bypass surgery 
(American Heart Association, 2007). 
 
The most important aspect of the development and progression of cardiovascular diseases and in 
the case of our experimentation, arterial disease, is the role of hemodynamics. Hemodynamics 
consists of the properties and flow of blood; these properties are pressure flow and resistance of 
circulated blood. Common hemodynamic measurements include cardiac output, stroke index, 
blood pressure, cardiac index and heart rate (International Hemodynamic Society, 2000). Arterial 
disease is the end result of the thickening or reduction in elasticity of the inner arterial wall. The 
internal mechanical forces acting on the inner arterial wall are the arterial pressure and shear 
stress. The wall shear stress is characterized as the tangential drag force experienced by the inner 
arterial wall caused by the pulsatile fluid flow of blood. Arterial wall shear stress has been 
credited with being the initial variable in the development of arterial disease with abnormal and 
irregularly experienced arterial wall shear stresses bringing about the development of arterial 
disease.  
 
The development of lesions and the formation of plaque along the lining of the inner arterial wall 
will be apparent within an artery exposed to abnormal levels of wall shear stress.  Damage to the 
arterial wall in this manner elicits a continued response by the body’s immune system resulting 
in the accumulation of fibrin, calcium, cholesterol, proteins, and other biological particles within 
the blood at the site of arterial damage. The accumulation of biological particles in this manner 
will eventually restrict pulsatile blood flow through the artery, minimizes the amount of oxygen 
to the surrounding tissues and causing further restriction and stress on surrounding regions of the 
cardiovascular system. 
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Advancements in detecting plaque build up and blockages of arteries are critical for 
atherosclerosis. Therefore being able to detect when an artery begins to have harden and thicken 
beyond normal aging is ideal. This idealism would decrease the number of incidents that occur 
with arterial disease. Currently recognition of atherosclerosis does not happen until the 
progression of the disease is sever. 
 
This project aims to both design and manufacture a pulsatile flow generator for the analysis of 
wave propagation in blood vessels for implementation in the early detection of arterial disease. 
This design should replicate pulse waves (pulsatile flow) within a physiological and should 
operate at a rate of 60 bpm or 1Hz. The system should also allow researchers to change the 
waveform morphology to correspond to different locations of the arterial tree. 
 
As the paper progresses, the group aims to provide an outlook into scope and methods of our 
project through the Literature Review, Project Approach, Design Approach, Results, Analysis 
and Discussion and finally the conclusion. All vital and pertinent information for a proper 
understanding of the project, such as the arterial disease states and their hemodynamic effects on 
the blood flow through the system, will be detailed in our Literature Review section. The Project 
approach will detail our aims and objectives, as well as, explaining the consumptions that were 
made through the course of the project. At this point the paper will transition into the Design 
aspects of the project and ending with a thorough analysis of our results. 
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2. Literature Review  
 
2.1. Circulatory System   
 
The circulatory system is composed of the heart, capillaries, capillary beds, veins, arteries, 
arteriole, venule and blood. A rhythmic beat is made by the heart; the beginning of this beat 
happens when there is an action potential in the sino-atrial node, this stimulation spreads to the 
atrio-ventricular node, which propagates the bundle of His. As a result, the heart produces what 
is more commonly known as a PQRST wave, a depiction of the atrial depolarization (P), the 
ventricular depolarization (QRS) and the phase of rapid repolarization of the ventricles (T). 
 
 
 
Figure 1: The PQRST wave 
 
Once blood leaves the heart it flows into the arteries, then from the arteries into the arterioles and 
then in the capillaries. As blood returns back to the heart via the veins it travels through the 
capillaries into the venules and lastly it ends up in the veins. The function of the arteries is to 
circulate oxygenated blood to the organs, where as the veins carry deoxygenated blood back to 
the heart to get oxygenated again. 
 
2.1.1. Blood 
 
Blood is a unique tissue in the body that has fluid properties that accounts from nearly 8% of 
body weight. Often known as the “River of Life” in ancient times, a healthy adult male has blood 
volumes of 5-6L while healthy females have 4-5L of blood. In the body, blood serves as a 
“vehicle” for the transportation of nearly every biological molecule. The general path of flow for 
blood is from the heart to the body, back to heart, to lungs and back to heart to be sent through 
the body again. Blood is a viscoelastic fluid that is composed of cellular and fluid components, 
that is, blood is composed of plasma and cells. The cells provide the elastic component of 
viscoelasticity and are also responsible for providing oxygen to the various tissues in the body. 
Atrial 
Contraction 
Relaxatio
n 
Ventricular 
Contraction 
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Plasma on the other hand provides viscosity component of viscoelasticity and carries all 
biological molecules, as well as provide an ideal environment to host blood cells. 
 
Blood performs many regulatory functions in the body. Blood helps maintain an appropriate 
body temperature by absorbing and distributing heat throughout the body. To prevent drastic 
body temperature fluctuations, blood is directed towards the skin surface to encourage heat loss 
or away from the surface to prevent heat loss. Blood also consists of large quantities of salts and 
blood proteins. Since proteins are sensitive to pH, a significant change could permanently 
damage the protein, thereby inducing massive damage to the native tissue. Therefore, buffers in 
the blood help maintain a very narrow range of pH. To perform this function, Carbon di-oxide 
(CO2) and other molecules are regularly bound or released to maintain a pH between 7.35 and 
7.45. This allows the body to utilize osmosis and control fluid loss to surrounding tissue in order 
to maintain adequate fluid volume and water content in the circulatory system. 
 
Blood is a sticky and opaque fluid that changes from scarlet (oxygenated) to dark red 
(deoxygenated). It also has a higher density then water. At a temperature of 37 degrees C, water 
has a density of 993.4 kg/m^3 while blood has a density of approximately 1060kg/m^3. 
Normally, blood is approximately 5 times more viscous then water. It also has a slightly higher 
temperature then body temperature. 
 
2.1.1.1. Viscoelasticity 
 
Viscoelasticity is an important property that is characteristic of most physiological tissues and 
fluids. Viscoelasticity is described as the ability of a material to show both viscous and elastic 
properties. Blood is also a viscoelastic material and is dependent on both viscosity and elasticity 
for proper flow through the body. For blood flow, the viscosity effects are generally attributed to 
plasma while the elastic properties are attributed to the blood cells, mainly red blood cells. 
Viscosity is generally related to the energy dissipated during flow, primarily due to deformation 
and sliding of RBCs and RBC aggregates. Elasticity refers to the energy stored during flow due 
to the deformation of RBC’s. In the body, viscoelasticity reflects a cumulative effect of many 
parameters such as viscosity, blood cell deformability, aggregation, etc. 
 
Why is viscoelasticity important? Blood flows in a pulsatile manner. As the heart beats, the 
viscoelastic properties of blood determine how the energy is stored or dissipated in the fluid. 
This is because RBC’s naturally tend to aggregate and stack together in a space efficient manner. 
These stacks must be reduced in order blood to flow freely. Therefore, once the energy is 
applied, the energy is stored into the cells due to elastic deformation and re-orientation of cell 
and cell microstructure, respectively. As the blood flows through the body, it requires continuous 
input of energy, which is dissipated through viscous forces such as friction. Therefore, since the 
blood exhibits both viscous and elastic properties, it is considered a viscoelastic fluid. 
 
Viscoelasticity profile of blood can be divided into three parts between low shear, medium shear, 
and high shear. Studies have shown that blood viscoelasticity is highly dependent on the rate of 
shear stress being applied. The three regions are as follow: 
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Region 1: Low shear rate: at low shear, the RBC’s are undisturbed and form aggregates, as 
mentioned previously, in a space efficient manner. In this region, viscoelasticity is 
dominated by red blood cell aggregates. 
Region 2: Mid-shear rate: at medium shear rates, the aggregates start to break down and the 
cells become increasingly disaggregated with increasing shear rates. The cells 
become deformed and somewhat oriented in the direction of the flow. In this region, 
the aggregates have increasingly lowered affect on the viscoelasticity of the fluid, and 
increased effect due to the deformability of the cells. 
Region 3: High Shear rate: At high shear rates, the cells are completely aligned in the direction 
of the flow, and viscoelasticity is influenced primarily by the ability of the cells to 
deform. A visual representation of the three rates can be observed in Figure 1. 
 
 
Figure 2: Viscoelasticity and shear rate relationship. 
 
 
2.1.1.2. Clinical Significance 
 
Blood rheology plays an extremely vital role in the development and progression of 
atherosclerosis and arterial disease. Literature details how specific regions along the arterial tree 
are more apt to the development of atherosclerotic plaque, fatty streaks, (Caro et al., 1971; Friedman 
et al., 1981) as well as, how the hemodynamics of these particular regions are not only controlled 
by the mechanical properties of the arterial but also by the rheological properties of the blood 
flowing in the aforementioned regions.  
 
The development of atherosclerosis has been attributed to many of the components of blood 
hemodynamics, which includes disturbed flow patterns (Hughes and How, 1995; Staalsen et al., 1995), 
low shear stress (Dobrin et al., 1989; White et al., 1993; Delfino et al., 1997), low and oscillating shear 
(Bassiouny et al., 1992; Taylor et al., 1998, 1999), temporal variation of the shear stress (Ojha, 1994), 
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spatial wall shear stress gradient (Kleinstreuer et al., 1996; Lei et al., 1997), and wall tension (Schwartz et 
al., 1992; Hofer et al., 1996). (Chen et al., 2005) 
 
2.1.2. Arteries 
 
2.1.2.1. Anatomy 
 
Arteries transport blood from the heart to the organs in the body. The anatomy of the artery is 
broken down into the lumen, tunica interna, tunica media, and the tunica externa. The lumen is 
the hollow center of the artery, which blood flows through. The inner most layer of the artery is 
the tunica interna and it is the closest to the lumen; consisting of endothelium, a basement 
membrane, and internal elastic lamina containing a simple squamous epithelium lining. The 
complete cardiovascular system has a continuous layer on the inner surface of endothelial cells. 
This endothelial lining of the blood vessel is usually the only layer to come into contact with the 
blood. 
 
The middle layer, generally the thickest layer, is the tunica media; the circularly arrangements 
around the lumen are elastic fibers and smooth muscle fibers. It is the abundant elastic fibers that 
cause arteries to have a high compliance. This high compliance means that the walls stretch or 
expand easily to the reaction of small pressure increases without tearing. The tunica externa is 
the outermost layer made up of elastic and collagen fibers. 
 
 
Figure 3: Arterial Anatomy (Fox, 1998) 
 
2.1.2.2. Arterial Properties 
 
The artery is considered a 3-dimensional structure comprised of parts which exhibit non-linear 
behavior, unequal physical properties along different axes or anisotropic behavior, and let us not 
forget viscoelastic behavior. Given the properties of anisotropic components varying with 
direction of applied stress and the properties of the viscoelastic components varying with time in 
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response to an applied stress or strain, these component behaviors and their respective 
mechanical properties allow us to make a general assessment of the properties of the artery. 
(Hayashi 1993) This assessment is one which concludes that an artery is simply a viscoelastic 
material. Due to its complex nature, it is quite difficult to simply define an arteries properties by 
one single descriptor. 
 
2.1.2.3. Mechanical Properties 
 
Arterial mechanical properties describe the characteristics that make up the tissue. The major 
mechanical properties include wall thickness, Young’s modulus, compliance, pulse wave 
velocity and radius. Below are tables which compare arterial and vein wall thicknesses. 
 
 Artery Arteriole Capillary 
Diameter 25 mm 30µ 8µ 
Wall thickness 2 mm 20µ 1µ 
Table 1: Arterial Wall Thickness (McDonald, 1974). 
 
 Large vein Venule-small vein 
Diameter 5 mm 20µ 
Wall thickness 0.5 mm 2µ 
Table 2: Vein Wall Thickness (McDonald, 1974). 
 
For the arterial wall the range of Young’s modulus is 2 - 8 x 106 dyn/cm2, which can be 
converted to 200 - 800 kPa.[7]  Young’s modulus is a proportion between the strain and the stress, 
stated by Hooke’s Law.  Here E is Young’s modulus, σ is the stress, and ε is the strain. 
 
 Equation 1 
 
Wall thickness and Young’s modulus usually remain constant in each specific artery assuming 
that the artery is healthy. If the artery is diseased, then these properties can change. Compliance 
and pulse wave velocity are two of the properties, which can change as the artery undergoes 
changes such as stiffening 
 
2.1.2.4. Impedance 
 
The human body, specifically blood is made up of many unique and independent parts which all 
have effects on how the total function of the body works. One of the main effects these parts 
have is impedance or resistance.  
 
Impedance is basically the resistance caused by any object. With respect to human blood, the 
impedance on the flow of blood can be considered any property or phenomenon which can 
hinder or alter the normal blood flow through the cardiovascular system. Some examples of this 
include, the viscosity of the blood itself, the plasma and cells contained in blood and some of the 
branching points of the arteries. 
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Since the viscosity of blood is a key factor in how it flows, any change in viscosity, due to 
whatever reason, can cause and increased or decreased resistance. This change in impedance 
would alter how the blood flows and alter the amount of pressure contained within the vessel. 
The plasma and cells contained within the blood act in a similar manner but the impedential 
effects of them are much less significant than that of viscosity. 
 
2.1.2.5. Compliance 
 
Before occlusion occurs, there is a critical stage in the development and progression of arterial 
disease. This vital stage in the disease process is the development and formation of plaque lining 
the inner arterial wall brought about by the prevalence of lesions along various points of the 
inner arterial wall. This initial thickening and reduction in elasticity, due to the formation of 
plaque changes the haemodynamics through the artery considerably, altering the structure and 
function of the inner arterial wall and the prevalence of disease (Fung, 1993).  
 
“A particular characteristic of the flow in stenotic vessels is the appearance of 
transitional/turbulent flow patterns, which in general are considered pathological in normal blood 
circulation. Although for mild stenosis the degree of stenosis is usually defined as a percentage 
diameter reduction the flow is likely to remain laminar, in moderate to severe stenosis conditions 
transitional and turbulent flow patterns appear in the post-stenotic area. Early in vivo velocity 
measurements point to a highly complex flow field with laminar, transitional and turbulent flow 
regimes coexisting in different spatial locations at various instants in time.” The wall shear stress 
is proportional to the velocity gradient at the wall and the fluid viscosity and is an estimate of the 
mean wall shear stress in the artery, as detailed in the following equation. 
 
3
32
D
Q
wall π
μτ = D  Equation 2 
 
Due to the complexity of the velocity gradient, in particular, testing and analysis of this 
characteristic, the group has decided to research the relationship between the change in pressure 
and the change in the elasticity of the arterial sample in order to determine how a small change in 
the stiffness of the sample correlates with a change in pressure. We are able to use the change in 
pressure due to the relationship between the pressure and the inner wall shear stress. One of the 
major haemodynamic forces acting on the artery is the transmural pressure across the thickness 
of the arterial wall. 
 
Arterial compliance, the viscoelastic property measuring the elasticity of the arterial wall, usually 
fluctuates with smooth muscle contraction and relaxation, therefore there can be many different 
types of curves to present compliance trends. In Figure 2 below, the compliance curves for both 
an artery and vein are shown. As can be seen, these curves are not linear. This is because the 
arterial wall tissue is not homogenous and therefore mechanical properties such as viscoelasticity 
play a major part in its functionality. This is because the arterial wall tissue is not homogenous 
and therefore mechanical properties such as elasticity end up having a non-linear change. This 
phenomenon is exactly what the group hopes to isolate and verify within the testing samples. By 
analyzing the compliance of a sample, the study group can gain a better understanding of what 
the mechanical properties of the sample are and if they compare to those in actual arteries (Fung, 
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1993). The compliance recorded can be both static or dynamic. For the purposes of this 
experiment though, because of lack of testing resources, the group has concentrated more on the 
static compliance of a vessel. 
 
 
Figure 4: Compliance curve for an artery and vein 
 
The group has decided to design a system which can be used to accurately observe the changes 
in radius of each sample. The compliance itself will be determined utilizing the following 
equations: 
⎟⎠
⎞⎜⎝
⎛ Δ= 100100 x
P
x
Ri
RC   Equation 3   ⎟⎠
⎞⎜⎝
⎛
Δ
Δ=
P
RC   Equation 4 
 
where C is the compliance,  RΔ  is the step change in radius of the arterial sample, P is the 
pressure at which the new radius was observed and PΔ  is the difference between the original 
pressure and new pressure (Avolio et. Al, 2002).  
  
These equations would allow for the group to have an understanding of the stiffness of each 
testing sample. By knowing the stiffness, the group would be able to determine the type of artery 
being tested i.e. diseased or healthy. The group would also look at pulse wave velocity 
calculations to confirm the findings of compliance testing. 
 
2.2. Arterial Disease States 
 
There are many disease states that can occur in the arteries such as atherosclerosis and stenosis, 
just to name a few. Atherosclerosis can be broken down into two components: athermatous and 
sclerotic tissue. Athermatous is “gruel, a soft and lipid-rich” where as sclerotic tissue is “hard 
and collagen-rich (Safar et al., 2002).” On an average more than 70% of the plaque volume is from 
sclerotic tissue, however it is moderately benign since smooth muscle cells secret collagen 
therefore stabilizing the plaque. Unlike athermatous, plaque is destabilized, consequently 
increasing the risk for formation of a thrombus (Safar et al., 2002). 
 
The initial observable changes of the artery due to atherosclerosis takes place in the endothelium 
of the artery and include the increased endothelial permeability to lipoproteins and other plasma 
constituents, up-regulation of  leukocyte adhesion molecules and the up-regulation of endothelial 
adhesion molecules into the arterial wall, which is detailed in Figure 3.  
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Figure 5: Initial Stages of Atherosclerosis 
 
The observed causes of endothelial dysfunction leading to atherosclerosis include elevated and 
modified low-density lipoprotein (LDL); free radicals caused by cigarette smoking, 
hypertension, and diabetes mellitus; disturbed regions of flow; genetic alterations; and/or 
elevated plasma homocysteine concentrations. 
 
The very next stage in the progression of atherosclerosis is the formation of fatty streaks. This 
type of lesion formation may be present throughout ones lifetime and is common in infants and 
young children. These fatty streaks initially consist of foam cells (macrophages containing 
lipids) together with T lymphocytes. Later, smooth muscle cells also appear in the fatty streak. 
The steps involved in this process include smooth muscle cell migration, T-cell activation, foam 
cell formation, and platelet adherence and aggregation. If these responses continue, they can 
thicken the artery wall. Due to this initial thickening, the artery compensates this by gradual 
dilation so that up to a point the lumen remains unaltered. This is known as vessel 
wall remodeling, which is detailed in Figure 4. 
 
21 | P a g e  
 
 
Figure 6: Fatty Streak Formation (image from Ross, R., 1999.) 
 
Now, as the fatty streaks progress and form into intermediate and advanced lesions, they tend to 
form a fibrous cap or thin layer that separates the lesion from the lumen, which is detailed in 
Figure 5. This formation represents a type of healing or fibrous response to the injury. The 
fibrous cap covers a mixture of leukocytes, lipid, and debris, which may form a necrotic core. 
These lesions expand at their shoulders due to continued leukocyte adhesion and entry. The 
necrotic core represents the result of apoptosis and necrosis, increased proteolytic activity, and 
lipid accumulation. At some point the artery can no longer compensate by dilation; the lesion 
may then intrude into the lumen and alter the flow of blood. 
 
 
Figure 7: Advanced Atherosclerotic Lesion (image from Ross, R., 1999.) 
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The rupturing of the fibrous cap or ulceration of the fibrous plaque can rapidly lead to 
thrombosis, which is detailed in Figure 6, and usually occurs at sites of thinning of the fibrous 
cap that covers the advanced lesion. Thinning of the fibrous cap is apparently due to the 
continuing introduction and activation of macrophages, which release matrix metalloproteinase’s 
(MMPs) and other proteolytic enzymes at these sites. These enzymes cause degradation of the 
matrix, which can lead to hemorrhage from the vasa vasorum or from the lumen of the artery and 
can result in thrombus formation and occlusion of the artery. The adherence and buildup of 
plaque is to follow this initial formation. 
 
 
Figure 8: Unstable Plaque 
 
The noticeable appearance for atherosclerosis is when the artery is very narrow or completely 
blocked, yet some symptoms that occur are “chest pain, pressure, tightness, or heaviness; leg 
cramps or pain with exercise; weakness on one side of the body; disturbance in speech, vision, or 
balance; abdominal pain or cramping (Fuster, Valentin, et al., 1999).” Treatments include prevention, 
lowering the risk by knowing health profile; lowering levels of cholesterol intake as well as 
triglycerides is prevention for decreasing the risk.  
 
Lastly there are drugs that are used to low the progression of the disease such as antiplatelet 
agents, fibrinates, and fish oils just to name a few (Recognizing the Symptoms. 1999). 
 
Stenosis is the blockage of an artery which can be caused by plaque build-up, such as that found 
in atherosclerosis (Recognizing the Symptoms. 1999). Basically stenosis is the diagnosis when there is 
significant atherosclerosis found within an artery causing severe enough blocked to greatly 
impede blood flow. 
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2.3. Stenotic Hemodynamics 
 
As aforementioned, stenosis is characterized by a narrowing and protrusion of the arterial wall 
consisting of a converging and diverging morphology. Bernoulli’s equation applies within the 
converging region of the stenosed artery but poiseuille’s law best describes the stenosed region 
of the artery. However, neither law governs the diverging region of the stenosed artery in which 
flow is turbulent and subject to viscous losses due its separation as it enters the region.  
 
 
Figure 9: Doppler time & velocity spectral for normal and stenosed blood vessels (Smith, 1991) 
 
The above figure characterizes the stenotic hemodynamics detailed above. One can clearly see 
the flow through a relatively average sized blood vessel starts off as laminar flow and as it enters 
the stenotic region, that same quantity of blood is forced through the narrowed region increasing 
the velocity. However as the flow of blood exits the stenotic region and flows into a region of 
increased area, the flow becomes turbulent as the velocity decreases suddenly. 
 
The protrusion of the arterial wall will also result in the fall in pressure distal to the stenosed 
region of the artery due to the increased resistance leading to the increase in loss of pressure 
along the entire length of the stenosed arterial region. (Young et al, 1973) This pressure loss, ∆P, 
when treated through semi-empirical relations, can be directly related to the flow, Q, with the 
following relationship,  
 
 
Figure 10: Flow through a Stenotic Region 
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  Equation 5 
 
 
 
  Equation 6 
 
where A0 = cross-sectional area of the unobstructed lumen, As = the area of the stenosed lumen, 
ρ = the fluid density, η = the fluid viscosity, ls = the length over which the pressure drop is 
measured and Kt which is an experimentally determined coefficient heavily dependent on the 
geometry of the stenotic region. 
 
The first term in the relationship represents the viscous losses, while the second term in the 
relationship, derived from the mechanics of flow in an expansive tube, represents the loss of 
pressure distal to the stenotic region. (Newman et al, 1979) 
 
This empirical formula for the ∆P across the stenotic region accurately depicts how flow, Q, and 
arterial area exist as quadratic terms detailing the hemodynamic activity of stenotic resistance 
increasing proportionally with flow. 
 
2.4. Pulse Wave Velocity 
 
When a heartbeat occurs, before the blood flow actually reaches a certain point in an artery, a 
pulse wave reaches that point. At any point where there is a branching of the artery, the wave is 
usually deflected back at a certain speed and goes back to its original starting point just before 
the aortic valve and dissipates in lieu of a new pulse wave created by the next heart beat. As an 
artery becomes stiffer, this pulse wave increases in velocity therefore the velocity after deflection 
also increases leading to the wave possibly reaching the aortic valve before it closes. This could 
lead to an unsafe increase in blood pressure. Basically, with age, the artery stiffens due to a wide 
array of issues and when this occurs, the pulse wave velocity number increases. The stiffer a 
vessel is, the higher its pulse-wave velocity would be (Fung, 1993). 
  
Pulse wave velocity studies are usually performed in vivo but for the purposes of this study a 
mathematical equation was used to calculate the pulse wave velocity using an experimental 
elastic modulus. Since the samples used do not recreate a branching point, pulse wave velocity 
was used as a way of confirming the health range of the arterial samples created. The pulse wave 
velocity would basically allow the group to understand, along with the compliance, the 
mechanical properties of the sample with relation to the study.  
 
If one considers the sample used as a isolated, cylindrical elastic tube and neglects the 
viscoelasticity of the material itself, then it can be assumed that flow inside the tube is basically 
one-dimensional with a longitudinal velocity component u(x,t) as a function of the axial 
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coordinate x and the time component t. Because of these assumptions two equations can be used 
as the starting point to derive the final equation (Macdonald, 1974). 
 
The equation of continuity 
 
 
0)( =∂
∂+∂
∂ uA
xt
A
  Equation 7 
 
 
 
and the equation of motion: 
 
01 =∂
∂+∂
∂+∂
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x
pi
x
uu
t
u
ρ   Equation 8 
 
 
From these two equations some other assumptions can be made such as that because cross 
sectional area A is dependent on the transmural pressure,  
 
pi – pe = P(A)  Equation 9 
 
then it can be assume that the mass of the tube is ignored as well. Since the mass is ignored, the 
differential equations seen above can be converted into or replaced by algebraic equations 
leaving a basic equation of 
 
dA
dPAC ρ=   Equation 10 
 
 
This however is not where the derivation would stop for the purposes of this study (Macdonald 
106). Because the group will be assuming its model to be an elastic tube, the derivation must be 
altered to include the Young’s Modulus, E. As seen in Figure 7 below, since there needs to be a 
balance of forces on the arterial wall, then new factors must be taken into account such as the 
circumferential strain and the wall thickness, h. 
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Figure 11: Balances of forces in an arterial wall 
 
Circumferential strain is denoted as. 
 
dai/ai  Equation 11 
 
 
When this number is multiplied by both the Young’s modulus, E, and the thickness, h, the 
equations would look like such. 
 
 
)(dpiai
ai
Ehdai =   Equation 12 
 
 
This equations is set equal to the product of the radius at a certain point, ai, and the change in 
pressure dpi 
 
 
ai
EhC ρ2=   Equation 13 
 
Therefore, the pulse wave velocity equation would be 
 
ai
EhC ρ2=   Equation 14 
 
 
 
but since the group did not assume that the model being used would be a thin-walled vessel, the 
equation must include the strain on the mid wall, therefore the final equations used would be 
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Equation 15 
 
where E, stands for the elastic modulus of the sample, R stands for the radius of the sample, h, 
stands for the wall thickness of the sample, ρ stands for density of blood and C stands for the 
pulse wave velocity. As this number increases, the stiffness of the artery does as well (Macdonald, 
1974). 
 
2.5. Prosthetic Models 
 
With the advent of biomedical enmgineering the rise of biocomptaible material, some focus in 
the industry has shifted towards fidning the correct type of material which could correctly mimic 
the mechanical properties of the human body. In order to gain an understand of the type of 
materials available that are clinically used for arterial treatment, the group felt it neccesary to 
research all known materials used clinically. 
 
2.5.1. Clinical Materials 
 
The ideal Arterial Blood Vessel Biomaterial Substitute should closely resemble the properties of 
natural physiological blood vessels as detailed in Tables 3 and 4.  
 
 
Modulus of Human Arteries 
Arterial Segment E (GPa) 
Thoracic Aorta .4 - 1.0 
Abdominal Aorta .4 - 1.5 
Iliac Artery .8 - 4.0 
Femoral Artery 1.2 - 4.0 
Carotid Artery .3 - .8 
Table 3: Modulus of Physiological Human Arteries (Ratner, 2004) 
 
Tensile Properties of Human Arteries 
Age (yrs) Tensile Strength (g/mm2) Elongation (%) 
10 – 19 137 – 143 96.6 – 101.4 
20 – 39 104.7 – 123.3 76.4 – 79.6 
40 – 59 99.3 – 108.7 64.5 – 71.5 
60 - 79 99.3 – 108.7 . – . 
Table 4: Tensile Properties of Physiological Human Arteries (Ratner, 2004) 
)2/(2 hR
Ehc += ρ
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Upon further review of the literature and commercial availability, etc., the group has condensed 
the polymer class of biomaterials to those most suitable to our application and testing. The 
mechanical and physical properties of those biomaterials can be found in Table 5. 
 
Table 5: Mechanical and Physical properties of Proposed Biomaterials (Ratner, 2004) 
 
These characteristics have been detailed in Table 6. 
 
Biomaterial Advantages Disadvantages 
Poly(ethyleneterephthalate) – 
PET – 
o Chemically Inert o Subject to hydrolysis  
o Low MW 
contaminants 
Polytetrafluoroethylene – PTFE 
– 
o Resistance to 
chemical degradation 
o Hydrophobicity 
o Low friction 
o Low wear resistance  
o Does not display 
typical thermoplastic 
flow behavior  
Poly(ether urethane urea) o High flex life 
o Range of mechanical 
properties 
o Uncertain molecular 
structure- property 
relationships  
o Surface radically 
different from bulk 
(high mobility of 
"soft segments")  
o Low MW contaminants 
Subject to hydrolysis, 
oxidation, and 
calcification 
 
Table 6: Proposed Polymer Biomaterials Comparison of Characteristics 
 
  
2.5.2. Latex 
 
Latex models of arterial vessels have been used previously in medical research. A research team 
in the United Kingdom found a way to manufacture latex tubing that had similar characteristics 
of human arteries. The artery in which this group mimicked was the superficial femoral artery. A 
7 x 10-3 m rod was for painting on the layers of latex. The procedure which was used comprised 
of painting thin layers onto the rod using a fine brush and letting it dry for 30 minutes before 
applying another layer. Once the latex was taken off the rod it was allowed to dry for 24 hours. 
Material Tensile 
Modulus 
(GPa) 
Tensile 
Strength 
(MPa) 
Elongation 
(%) 
Tg (°C) Tm (°C) Water 
Absorption 
(%) 
Water 
Contact 
Angle (°) 
PET 2.8-4.1 59-72 50-300 69-82 265-270 0.1-0.2 73-78 
PTFE 0.4 14-35 200-400 -10 327 0 110 
PE 0.1-0.3 4-16 90-800 -20 95-115 .009 93-95 
Polyurethane .07 31-41 600-800 (-)53 – (-)67 120-150 .02 63-69 
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The various testing that was done to compare the latex models to that of human arteries were 
compliance, pulse wave velocity, and Young’s modulus. The results of the experimentation were 
that compliance ranged between 337.5 x 10−12 to 900 x 10−12 m3 Pa−1 m−1 which covers in vivo 
ranges that have been observed; Young’s modulus was measured to be 0.61 x 106 Pa which 
compares to published data by Duck in 1990, human arteries range between 0.3 x 106 and 5.5 x 
106 Pa; lastly the pulse wave velocity ranged from 6-9 m/s which was 5-15% lower than the 
predicted value. The end conclusion was that latex models were similar to that of human arteries 
except for the increased compliance at higher pressures (Walker et. al., 1999). 
 
Another group of researchers at Brunel University have used latex tubes to model arterial waves. 
The wave of particular significance to the group was the wave from the heart to the feet which is 
about 2 m. The lengths of the latex tubes were 2 m,  the diameter range was 4 -16 mm, the wall 
thickness range was 0.1 - 0.2 mm, wave speed was 3.5 - 7.1 m/s, and the compliance was 0.024 - 
4.55 10-8 m2 Pa-1. The outcome was that bigger pulse pressure was observed in the smaller tubes 
in comparison to the larger ones; there were also greater wave intensities in the smaller tubes 
than the larger tubes (Feng et. al., 2006). 
 
A different group in the United Kingdom used latex modeling to look at the waveforms after an 
aneurysm by monitoring intrasac pressure (ISP). Here they found that intrasac pressure had 
significant drop relative to arterial blood pressure (Chaudhuri et. al., 2006). 
 
From the literature what is observed is comparative data when using latex for arterial modeling, 
therefore encouraging the use of latex for our experimental analysis. 
 
2.5.3. Comparison of Prosthetic/Latex/Human Arteries 
 
It is pertinent for experimentation to find a material that is very similar to that of human arterial 
mechanics when making a physiological model. Arteries have a Young’s Modulus of 3.21 x 105 
Pa, where latex arterial models are 0.61 x 106 Pa and PTFE is 0.4 x 109 Pa. Compliance and 
Young’s modulus values can be seen in the table below (Feng et. al., 2006). These values were 
taken from a study where latex models were also used, but the morphology of their models were 
quite different than the ones that would be used by the group. Differences in wall thickness and 
radius would lead to different compliance values. The group would create latex models that 
would be compliant enough to fall within a physiological range. These values show that although 
PTFE would be a better substitute, latex can still serve as a good model.  
 
 
Material Young’s Modulus Wave Speed Compliance 
Artery 3.21 × 105 ± 2.11 × 
105  Pa [3] 
4 – 20 m/s [1] 68 x 10−12 m3 Pa−1 
m−1 [2] 
Latex Model 0.61 x 106 Pa 6 - 9 m/s 337.5 x 10−12- 900 x 
10−12 m3 Pa−1 m−1 [2] 
PTFE 0.4 GPa  1.6 % diameter 
change/mmHg x10-2 
[4] 
Table 7: Comparison of Mechanical Properties of Arteries, Latex models and PTFE. 
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Another reason why latex should be used in comparison to PTFE is cost. Latex by the gallon is 
$39.95 where different types of models can be made; unlike PTFE which is about $4 per foot but 
with this type of testing custom models are need and that is more expensive. 
  
2.6. Mechanical Flow Systems 
 
2.6.1. Pulsatile Flow Generators 
 
In order for blood flow to be mimicked, a system must be used which can recreate the pumping 
action of the heart. Studies usually yield two different ways of creating this pumping action; a 
slider-crank system or a cam-follower system. They are both systems in which a piston and 
flywheel are incorporated with each system having its own advantages and disadvantages. 
 
2.6.2. Cam-follower 
 
The cam-follow system is a pumping system in which the timing and force put on the piston is 
actually controlled not only by the motor, but also by the shape of the cam itself. As seen in 
Figure 7 below, the flywheel or cam is not in a circular shape. Rather its shape has been 
determined using physical analysis taking into account the amount of force needed on the piston 
along with the displacement of the piston with time. The cam can actually be produced using 
different types of software which exist such as DynaCam. This software program allows one to 
create the cam one would need in order to produce the type of flow wave desired.  
 
 
Figure 12: Cam-Follower System 
 
Its shape for the most part is an oval shape with different types of small bends or concaves in 
order to mimic the action of the heart as much as possible. Its oval shape with the bends and 
concaves allows for the “break” between pumps to occur and since the human heart does have 
the split second pause between pumps, this system is thought to be very close to how the heart 
pumps blood. Also the amount of revolutions of the cam can be controlled by the motor power 
and rpm.  
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Although the cam follower system seems to be a very good way to mimic the human heart and 
how it pumps blood throughout the body, it does have its disadvantages. One problem is friction 
which can occur between the follower and the cam surface. Since the follower follows the path 
of the cam, eventually friction can occur causing a slight altering of the path. When this occurs, 
the wave created by the contour can be altered as well. This system must follow very strict 
precision constraints otherwise it will not produce the results needed. The friction can especially 
be a problem at high speeds because the cam follower may not move as fluidly as needed at high 
speeds in order to attain a good pumping action. Even though many use lubrication such as ester 
based oils to keep the friction low, overtime this hesitation can still occur (Makoto et. al., 2005). 
 
Another problem that can occur with the cam-follower system is that wear on the cam caused by 
the follower can redistribute the pressure placed on the cam. Basically you start to get a cam 
contour which is no longer smooth but rather bumpy causing an inaccurate flow wave to be 
produced. (Anders et. al., 1996) 
 
A third problem with the cam-follower system is that the cam-follower system assumes a 
constant camshaft speed. At high speeds though, all cam-follower systems exhibit some camshaft 
speed fluctuation, which can lead to follower inaccuracies and distortions. [16] Since every cam-
follower system is theoretically different though, the “high-speeds” which can cause this 
fluctuation may be lower in different models. Therefore, with the cam-follower system 
effectiveness testing must be performed in order to accurately observe that max speed at which 
the system still runs properly. 
 
 
2.6.3. Slider Crank 
 
The second type of pulsatile flow generating system is the slider-crank system. This system is 
similar to the engine of most cars. It differs from the cam-follower system in that the piston is 
directly connected to the cam or flywheel via a connecting rod. Therefore the cam itself does not 
have an oval shape but rather a circular shape.  
 
The slider-crank system offers advantages in that some of the frictional problems with the cam-
follower system are solved. Since the piston is directly connected to flywheel, the only concern 
about friction would be in the tube where the piston pumps, but this can be easily 
overcome using a good long lasting lubricant and does not present as much of a frictional issue 
as does the cam-follower system.  
 
A second advantage is that the slider-crank system allows for the control of the flow to come 
from control over the motor rather than from the contour of the cam. This allows the researcher 
to be a bit more precise as long as the motor can be controlled properly.  
 
The slider-crank system is one which the kinematics plays a major role. As seen in Figure 8 
below, there are many unknowns such as angles and lengths which must be calculated in order to 
get a good working system that has no hesitations or pauses. 
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Figure 13: Slider- Crank Mechanism 
 
By performing simple kinematic analyses on the whole system using the equations seen in Figure 
9 below, the vital unknowns such as omega, and the length of the connecting rod, L, can be 
calculated. The analysis for this project can be seen below in Table 7. 
 
 
 
 
Figure 14: Kinematic equations 
 
 
There are also some disadvantages of the slider-crank system though. The piston head and the 
connecting rod must be at a perfect positioning in order for there to be enough clearance for the 
connecting rod to move up and down as it is turned by the flywheel. This can be overcome as 
long as the physical calculations seen above are done correctly. The calculations take into 
account that enough space is needed so that the connecting rod does not come into contact with 
the wall of the piston head, thereby causing a hesitation or pause in the fluid movement of the 
system (Corbo et al. 1999).  
 
A second problem is that since the slider-crank is in constant motion, the flow wave it would 
produce would be just a normal sine wave. Unfortunately this result would not tell the research 
group anything as the human body does not produce a normal sine wave. To overcome this 
problem, the slider-crank system must be controlled through the motor. To control the motor, a 
motion controlling device must be included in the system in order to direct the motor to produce 
the right type of wave needed. By including this motion controlling device, the now modified 
slider-crank system offers even more potential as a full-time multi-use pulsatile flow generator. 
Basically, with this controlling device, any type of wave can be created by the motor/system by 
just altering the settings. 
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2.6.4. Comparison of Flow Systems 
 
In order for the group to come to a reasonable decision about which type of pulsatile flow 
generator to use. The group felt it was important to look at both the cam-follower system and the 
slider-crank system and compare/contrast the two systems to see which would best fit the type of 
testing the group would be performing. 
 
Both the cam-follower and the slider-crank have there advantages which were stated previously. 
The cam-follower is a simple system where the contour of the cam controls the wave profile 
which is produced by the entire system. The important aspect when creating the cam is to take 
into account the trough which serves as the slight pause between the pulses. The height and 
length of the concave will determine how long that pause is and also determine how much of a 
curvature the cam has on its side. This means that the length and height of that concave 
determines the amount of force the cam places on piston which would force the blood substitute 
through the system. The physical specifications of the cam can be created using various software 
such as DynaCam. 
 
The slider-crank also has its advantages as stated previously. The difference with the slider-crank 
is that the control of the flow is not in the cam but with the motor. The physical calculations of 
the slider-crank rely much more on kinematical analysis. The kinematical analysis performed by 
the group on the slider-crank design can be seen above. It is not as easy to have a slider-crank 
produce the wave profile desired but if controlled correctly it can produce a much more accurate 
wave profile for a longer period of time. 
 
Both also have some drawbacks. The biggest drawback with the cam-follower is consistency and 
longevity. A cam-follower is a simpler setup but with possible friction between the roller and the 
cam and also vibration which may occur from the 
cyclical motion of the oval shaped cam can be detrimental to a wave profile. A slider-crank has 
problems as well. The ability to control the system and be able to produce the desired wave is not 
an easy task and basically calls on a group to use some kind of motor control in order to harness 
the ability of the slider-crank system and be able to produce the desired wave. 
 
Considering both the negatives and positive of the cam-follower and slider-crank systems, the 
group has chosen to incorporate a slider-crank system for their pulsatile flow generator. The 
group feels that the slider-crank will provide the group with a much more accurate wave profile 
for a longer period of time than the cam-follower system. Also since the physics have been 
completed the group feels that by using the a motion controlling device to control the motor, the 
group will be able to harness the abilities of the slider-crank system and be able to produce the 
desired wave in order to commence proper testing. 
 
2.7. Motion Control 
 
2.7.1. DC Motors 
 
DC electric motors are comprised of a coil, which when powered generates a magnetic field 
around the armature. The left end of the armature is pushed towards the right away from the left 
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magnet resulting in a clockwise rotation. The armature continues to rotate in this manner until it 
reaches a horizontal alignment, at which the commutator reverses the current through the coil, 
thus reversing the magnetic field. As this process continues, circular motion is created. 
 
       
Figure 15: DC Motor Motion 
 
The speed of the motor depends on the flow of current and voltage to the motor coils, as well as, 
the motor braking torque. The speed is directly proportional to the voltage and the torque to the 
current. Varying the current or voltage will vary the speed of the motor. Constant current makes 
the motor produce a constant rotational motion, while varying current changes the rotational 
velocity of the motion. DC motors feature the capability of adjusting the speed smoothly to zero 
following acceleration in the opposite direction, in addition to responding quickly to control 
signals, primarily resulting from the DC motors high torque to inertia ration. 
 
2.7.1.1. DC Stepper Motor 
 
DC Stepper Motors provide a number of advantages including but not limited to feedback signal 
compatibility and acceleration. Stepper motors can easily bring a load to acceleration. The DC 
stepper motor is comprised of one electromagnetic pole and a rotating arm with a constant north 
or south pole, with the outer poles charging from off to on and vice versa. These motors allow 
for continuous rotational motion but in steps. Stepper motors experience high torque at very low 
speeds, while at the same time being subject to decreasing torque at high speeds. 
 
2.7.1.2. DC Brushless Motor 
 
DC brushless motors, despite their exceptional qualities, are not comparable to its counterpart in 
the motion control arena. Brushless motors are comprised by a wound stator surrounding a 
permanent magnet rotor. The inverse of typical motors, especially given that its windings are 
commutated electronically rather than by the more common commutator and brushes like its 
counterpart. DC brushless motors offer benefits not only with price but also with energy, 
maintenance, as well as, the ability to operate at higher speeds than its counterpart. Its high 
efficiency and favorable attributes make it a common choice for motion control systems and 
applications. 
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2.7.2. Motion Controllers 
 
2.7.2.1. ION Digital Drive 
 
Differential Encoders allow for the detection of rotary positions by means of a code-wheel 
attached to a dual shaft motor. The differential encoder employed in the development of our 
pulsatile flow generator is a transmissive optical encoder with a 1000 Index channel. (Figure 1) 
The Encoder consists of a lensed LED source and a monolithic detector IC enclosed in a small 
polymer package. The encoder uses a phased array detector technology in order to provide 
digital quadrature differential outputs on all resolutions. The encoder attachment can be seen 
below. 
 
    
Figure 16: Pulsatile Flow Generator Motion Control System 
 
The group utilized a motion control device which will allowed us to establish servo control of 
our motor in order to achieve a higher resolution, smoother motion, and a lower holding torque. 
These parameters were achievable through the connection of the motion control device to the 
Differential Encoder on our DC Brushless motor. 
 
The Performance Motion Devices (PMD) ION Digital Drive is a complete single-axis motion 
controller with integrated power, as well as a network communications port, providing advanced 
motion control features in a compact and manageable form factor. With the addition of the ION 
Digital Drive, the group was able to take advantage of many of its features, such as encoder 
position feedback, position servo compensation, its brushless DC motor commutation, as well as, 
the ION’s digital current/torque control. 
 
One of the most important features of the ION Drive was the protection of its high power drive 
stage from overcurrent, undervoltage, overvoltage, over temperature and short circuit faults, 
affording us the safety of operating our DC brushless motor and the prevention of some advserse 
interaction resulting from a spike in the current or drop in the voltage from our power supply. 
The ION Drive acted as a last line of safety defense for all other components in our system with 
the aforementioned safety features, as well as, dedicated Enable input and Fault output safety 
interlocks. 
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Figure 17: ION Digital Drive 
 
The very heart and soul of the ION Digital Drive is the Magellan Motion Processor (Figure 2), 
which allowed the ION to deliver the following motion control functions to us even given the 
dated PC system we were working with: 
 
o Serial host communications over RS232 
o Trajectory generation, including trapezoidal and S-curve point-to-point profiling, velocity 
contouring, as well as, electronic gearing modes 
o Advanced PID position loop with integration limit, derivative sample time, velocity and 
acceleration feedforward output bias, dual biquad filters, and support for dual encoder 
feedback if needed 
o Two encoder input channels capable of up to 10 Mcounts per second 
o Sinusoidal and six-step (Hall) brushless DC commutation modes 
o Digital current loop with choice of standard A/B or Field Oriented Control (FOC) for our 
brushless DC motor 
o Single phase current loop 
o High-efficiency MOSFET power stages for our three-phase brushless DC motor. 
o 15 A RMS peak current capability with I2t current foldback limiting 
o Choice of 20 kHz or 40 kHz PWM frequencies to support a broad range of motor 
inductance. 
o Single supply operation (An onboard DC/DC converter supplies all internal circuitry and 
also provides 5V for encoders and other external I/O components) 
o Differential or single-ended encoder input buffers for all encoder channels 
o Signal conditioning buffers and analog filters on all I/O signals 
 
The basic premise is to utilize the motion control device to generate the flow waveform we are in 
need of. 
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Figure 18: ION Digital Drive Schematic 
 
 
2.7.3. Servo Loop Tuning 
 
Servo Loop Tuning is basically the process of adjusting servo system parameters in order to 
achieve an output signal that closely resembles the input signal. This becomes extremely 
important when trying to output a specific pulsatile pressure waveform given that both the motor 
and piston slider crank assembly introduce inertia into the system, which forces the servo 
amplifier to accelerate and decelerate to overcome while following the input signal as closely as 
possible. Thus, a balance between the need for a high response rate (high gains) and stable 
operation (low gains) must be achieved. 
 
Servo motion control is represented by two classes. The first class involves command tracking, 
addressing how well the output signal (actual motion) closely follows the input signal 
(commanded motion). The most commonly used commands in typical rotary motion are the 
position, velocity, torque and acceleration commands. The Feedforward control is the part of the 
controller that deals with these commands, acting as the internal commands working to make 
sure that the input commands are followed without error. 
 
The second class exists to address the disturbance rejection characteristic of the system, with 
disturbances resulting from torque disturbances on the Brushless DC motor shaft, as well as, 
incorrectly estimated motor parameters utilized in the feedforward control. In order to rectify and 
prevent these issues a Proportional Integral and Derivative (P.I.D.) position loop control is 
utilized. The disturbance rejection control in contrast to the feedforward control, which estimates 
the needed internal parameters for a “0” following error, reacts to any unknown disturbances and 
estimation errors and attempts to rectify or prevent them. A complete servo system is one in 
which both of these controls are combined providing a substantial level of high performance. 
 
 
38 | P a g e  
 
2.7.4. Proportional Integral Differential Controller (PID) 
 
The Proportional Integral Differential Controller is an alternative to the typical on-off control 
method of motors and motion. PID involves the establishment of a set point and measurement in 
order to determine the “error” as detailed below: 
 
{(error) = (set point) – (measurement)} 
 
The Set point is the commanded value and the measurement is what the actual value is. The error 
would then be the difference between the set point and actual value. 
 
 
Figure 19: PID Analysis 
 
As aforementioned, a typically servo controller consists of a trajectory and P.I.D. controller, with 
the trajectory controller generating position set points and the P.I.D. controller functioning on the 
position error calculated and generating a torque command to the DC Brushless motor. The 
P.I.D. controller consists of 3 gains that are adjusted and which act on the position error, Kp, Ki, 
and Kd. 
 
 
PID Control Loop Parameters 
 
Proportional Gain (Kp) - Proportional gain is the system stiffness. It determines the 
contribution of restoring force directly proportional to the position error. Restoring force is 
comparable to a spring in a mechanical system. A high proportional gain gives a stiff 
responsive system but can cause instability from overshooting and oscillation. 
 
Derivative Gain (Kd) - Derivative gain is the damping effects on the system. It determines 
the contribution of restoring force proportional to the rate of change (derivative) of position 
error. This force is much like viscous damping in a damped spring and mass mechanical 
system—a shock absorber, for example. Increasing derivative gain reduces oscillation at the 
commanded position, or it rings because of high acceleration. 
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Integral Gain (Ki) - Integral gain is the static torque load on the system. It determines the 
contribution of restoring force that increases with time, ensuring that the static position error 
in the servo loop is forced to 0. This restoring force works against constant torque loads to 
help achieve zero position error when an axis is stopped. Integral gain improves positional 
accuracy. High static torque loads need integral gains to minimize position error 
when stopped. (Understanding Servo Tune – Tutorial - National Instruments) 
 
 
Derivative and/or integral terms are added to proportional controllers to improve qualitative 
properties of a particular response. The PID motor voltage control schematic is detailed in the 
figure below. 
 
 
Figure 20: PID Voltage Control Schematic 
 
2.8. Pressure Measurement 
 
Ones ability to measure the systolic and diastolic blood pressure accurately, as well as, the other 
parameters closely related to the blood pressure such as the heart rate and blood flow parameters 
is of great significance when conducting arterial studies. 
 
2.8.1. Indirect Blood Pressure Measurement 
 
The most common non-invasive (indirect) blood pressure methodology utilizes a cuff technique. 
This methodology consists of the placement of a cuff proximally on the subject to occlude flow. 
The cuff pressure is measured by determining the cuff pressure where corresponding changes in 
blood flow are observed during the occlusion and release of the cuff from the subject. The blood 
pressure sensor located distal to the cuff on the subject will measure the blood pressure being 
observed. There typically three blood pressure measurement techniques utilized, the volume 
pressure recording, photoplethysmography and piezoplethysmography. In addition to these 
techniques, an increasing number of sensors such as but not limited to photoelectric sensors, 
Doppler sensors and acoustic sensors. Regardless of the sensor being utilized or the technique 
being employed, one variable remains constant in indirect measurement and that is the 
requirements of the cuff. 
 
The non-invasive methodology has 4 primary advantages in blood flow studies. Firstly, being 
non-invasive, they do not require any surgery. Secondly, they can be utilized to obtain 
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measurements in conscious subjects in blood pressure and flow studies no matter the duration. 
Thirdly, they are far less expensive than their counterparts. Fourthly, they can be used on a wide 
array of subjects in order to provide an outlook on hypertensive cues. (Pfeffer et al, 1971) 
 
However, with advantages comes disadvantages, especially with the indirect method of blood 
pressure measurement. This form of blood pressure measurement suffers from three major 
drawbacks. The first drawback is the methods ability to only be capable of capturing blood 
pressure measurements within a restricted time frame or in other words a small number of 
cardiac cycles, which ultimately results in its lack of truly depicting a subjects average blood 
pressure. The second drawback is the fact that this technique also introduces significant stresses 
into the cardio system affecting the blood pressure and resulting in distorted readings of blood 
pressure and heart rate. Lastly, the accuracy of this methodology has given rise to scrutiny, 
especially due to the results of comparison from its direct measurement counterpart shows 
inconsistencies. (Hartford et al, 1996) 
 
2.8.2. Direct Blood Pressure Measurement 
 
The most common invasive (direct) blood pressure methodology utilizes a catheter based 
technique. Blood pressure is measured by means of invasively situated fluid-filled catheters 
connected to external transducer which relays the signals to an amplifier and recording device, 
which in many cases is a software application. This technique is not only subject to widespread 
use, it is also one of the oldest techniques still utilized. The versatility of this system allows for 
effective utilization in studies for a prolonged length of time. 
 
This technique offers many advantages over indirect measurement techniques in that it is more 
accurate and reliable and allows for the assessment of blood pressure variations. In addition, it 
currently the most accurate technique for measuring the Mean Arterial Pressure (MAP) directly. 
Adding to its advantages is the fact that the technique is relatively inexpensive, with catheters 
and transducer running quite low in price. Lastly, the technique allows for novel flow and 
vasculature studies by researches due to the availability of the arterial vasculature to researchers 
utilizing the technique.  
 
There are however disadvantages to using this system, which can easily be overcome with solid 
and thoughtfully designed methodologies. Such disadvantages include the damping of blood 
pressure signals due to growth on and or clotting of the tip of the catheter. This is a growing 
concern in catheters utilized in this technique that are larger than PE10, which can also cause 
under damping and pressure signal distortions. (Mattson, 1998) 
 
2.9. Wave Analysis 
 
2.9.1. Fourier Transform 
 
Fourier transform is an analysis of which relates two hemodynamic variables, in our situation 
pressure and flow. If pressure and flow were to be analyzed by just division the information 
would be meaningless because there would be infinite values when looking at diastolic pressure. 
Therefore what Fourier transform does is convert pressure and flow into a series sine waves. A 
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harmonic, also called the sine wave, has an amplitude and phase angle; each sine wave in the 
series has one. The harmonics are linked to the heart rate, the frequency of the heart is equal to 
the first harmonic, twice the heart rate is the second harmonic, and so forth. As the harmonics are 
increased the amplitude decreases but the converted information includes more of the actual 
detail of the pressure wave.  
 
The analysis of Fourier provides information on the time and linear invariant system through the 
calculation of amplitude ration and the difference of the phase angle per harmonic. The 
limitation in using Fourier transformation analysis is that the beginning and ending waves should 
be the same and so should all the waves that are analyzed. Another limitation is for higher 
harmonics there is more noise in comparison to lower harmonics. Also in order to do a steady 
state oscillation calculation relationship the two signals must be linear. Lastly the analysis for 
Fourier is only done in multiples of the heart rate, giving a limitation to the frequency resolution. 
 
2.9.2. Fast Fourier Transform 
 
Fast Fourier Transform provides the same analysis as normal Fourier Transform but in a sped up 
version. The FFT works through an algorithm created by Cooley and Tukey in 1965 which is a 
faster way of analyzing complex series by raising the number of points in a series by the power 
of 2 (Bourke, 1993). 
 
2.9.3. Short Fourier Tranforms 
 
The regular Fourier transform is unable to analyze time from point to point on the graph; 
however the way of overcoming this is by simultaneously comparing the localized time and 
frequency domains together which is referred to as Short Time Fourier Transform. By using this 
tool, there can be a more specific analysis of each point found on a wave (National Instruments, 
2007). 
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3. Project Approach 
 
3.1. Objectives 
 
The objective of this project was to design a pulsatile flow generator for the analysis of wave 
propagation in blood vessels for implementation in the early detection of arterial disease. This 
intention required the development of a system which would replicate a pulse wave (pulsatile 
flow) within a physiological fluid at a rate of 60 bpm or 1Hz while at the same time offering the 
ability to change the waveform morphology to correspond to different locations of the arterial 
tree. In order to guarantee that our project satisfied our object it was necessary to develop a 
validation methodology which would allow us to compare results gained from system to those 
found in literature. This would need to be accomplished by developing physiological arterial 
models and examining the harmonics produced from each model ranging from healthy to 
stenosed regions. 
 
3.2. Aims 
 
The specific aims of our project are as follows: 
 
o To develop a pulsatile flow generator that develops arterial pressure waves 
o To replicate arterial pressure waves within a physiological pressure range (60mmHg-
120mmHg) 
o To generate a pulsatile flow resulting from a frequency of 1Hz or 60 bpm 
o To accurately emulate multiple pressure waveforms corresponding to various locations on 
the arterial tree 
o To create and utilize a physiological fluid with a viscosity close to 4.0 cP 
o To fabricate and test physiologically viscoelastic arterial models 
o To develops arterial models ranging in increasing thickness and stenosis 
o To analyze the pressure waveforms produced by the pulsatile flow generator system and our 
samples 
o To examine the FFT produced from each waveform and quantitatively compare our results to 
those found in literature 
 
3.3. Assumptions 
 
The most critical assumption that was made in our design of the pulsatile flow generator was the 
scale-up of the latex arterial models that we planned to utilize in the physiological validation of 
our system. The models were scaled-up up from a lumen size of 6mm to a lumen size of 1 inch. 
This was primarily due to the inability of our group to procure synthetic materials with an initial 
lumen size of 6mm in varying degrees of stiffness and diameter. 
 
Scaling of the models in size also required us to scale the system up, especially with respect to 
the fixation system in order to accommodate the models. Although the system and models were 
scaled we felt the data we recorded during experimentation was still accurate and significant due 
to our insistence that our model operate within a physiological realm and that our models 
represent as closely as possible physiological human arteries. Establishing that our models did 
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indeed represent human arteries with respect to its viscoelasticity and morphology we concluded 
that our results should still be able to accurate validate our system. Of course given access to 
greater resources and time, the models should be scaled back down in order to be used with 
animal arteries, etc.  
 
Assumptions were also made with respect to the blood substitute the group utilized, as well as, 
the arterial models we created. Blood is a viscoelastic fluid that is composed of cellular and fluid 
components with the cells providing the elastic component of viscoelasticity and the fluid 
providing the viscosity component. The blood substitute that the group used in the validation 
testing accurately mimicked the viscosity of whole human blood, but did not necessarily mimic 
the cellular components of blood. Given this issue, we had to assume that although blood 
rheology has a direct correlation with the development and progression of atherosclerotic plaque, 
that the effects of the blood rheology would not have a significant impact of the validation 
testing we were aiming to do on our system. Since we were testing multiple pre-developed 
models with varying thickness and stenosis to model the progression of atherosclerotic plaque, 
we felt the makeup of our blood substitute could be considered negligible as long as it 
maintained the same viscosity as whole blood. 
 
The models also exhibited the same issues with its mechanical properties and composition. As 
arteries are simply consist of many components including but not limited to elastic, connective 
tissue, and smooth muscle and our models did not, we had to make an assumption as to the 
significance of the makeup of our arteries to its mechanical properties. As our models exhibited 
comparable mechanical properties to arteries in vivo such as their compliance and pulse wave 
velocity, we felt that we could assume its uniform makeup of just latex as negligible given our 
objectives with the project. 
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4. Design Approach 
 
4.1. Design Iteration 1 
 
The first complete pulsatile flow generator designed by the group can be seen in the CAD 
view below in Figure 10 with a CAD view of the base itself in Figure 11. The system 
called for the tubing to be mounted to a back wall. This was done in the hoped of 
reducing any positble vibrations that may occur in the plastic tubing, causing data to be 
flawed. The only parts of the design not shown in the schematic below are the motor and 
motion control device which are found behind the flywheel at point A. 
 
 
 
Figure 21: Design Iteration One 
 
 
A Flywheel 
B Connecting 
Rod 
C Piston Head 
D PTFE Hard 
tubing 
E Clamp and 
position of 
1st transducer
F Sample 
tubing 
G Clamp and 
position of 
2nd 
transducer 
H End of tube 
and position 
of valve 
Table 8: Design Iteration One 
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Figure 22: Base for Flow Generator 
 
4.1.1. Slider Crank System 
 
The first Iteration of the slider-crank system called for the use of a DC Brushless motor with a 
peak torque of 25oz-in and a peak current of 3.5A (Anaheim Automation). After some kinematic 
and force calculations were performed to try to calculate the amount of force needed to push the 
piston against the 80mmHg of pressure within the tubular system, the group chose to use this 
motor because it was thought to supply enough power to push the piston. 
 
To control the motor itself in order to produce the desired physiological pressure wave, the group 
decided upon using the Labview software program. The group felt that by using Labview the 
group would be able to easily control the motor output. 
 
4.1.2. Pressure and Flow System 
 
The test bed for design iteration one, or the pressure and flow section of the system consisted 
mostly of opaque PVC tubing. PVC tubing is a commonly used type of plastic tubing which is 
very strong and will not be effected by the amount of pressure the group was to buil up within 
the system. Also since PVC is a commonly used tubing, the group felt it would have more of an 
array of sealants to choose from if the use of it became neccesary. 
 
The PVC would be connected to the sample using a common plumping fitting. At one end of 
each fitting the PVC would be locked into place and on the other end, the group’s sample would 
be attached. This aspect of the system can be seen at points D, E, F,and G in Figure 1 above.  
 
The introduction of the blood substitute into the system would be done using a reservoir placed 
above the entire system. Using a modified paiting bucket, the group would rely on gravity to 
bring the substitute into the system. The bucket used had a five gallon capacity which the grouop 
thoguht would be sufficient for the purposes of the study. 
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Since the entire system itself would need to be pressurized in order for there to be a proper 
simulation of human blood pressure, check valves were needed both at the entry point of the 
fluid and the exit point. These chech valves would allow the group to build up the proper amount 
of pressure within the system. The group chose to place simple two-way ball valves at the entry 
point of the fluid from the reservoir and the exit point prior to the fluid entering the recirculation 
reservoir. With system calibration, the group would open and close these two valves to a certain 
point and build up the pressure within the system. The exit valve, which was found to have to 
most control over the amount of pressure in the system can be seen in Figure 1 above at point H. 
 
4.1.3. Recirculation 
 
In order to avoid having to manually refill the reservoir every time a test were to be run, the 
group felt it neccesary to a devise a recirculation system. This recirculation system would not 
only allow for more efficient testing, but would also allow the group to keep a constant flow in 
the system, thereby avoiding any sudden pressure decreases which could flaw the data acquired. 
 
To recirculate the blood substitute, the group chose to fill the introdcutory reservoir by using a 
simple drill pump. The drill pump is a small handheld pump which would be attached to any type 
of power drill. Tubing from one side of the drill pump would be attached to the introductory 
reservoir and tubing from the other side would be attached to the end of the pulsatile flow 
system. Although the drill would need to be working at high speeds, the drill pump did provide 
sufficient head to raise the blood subsitute back into the overhead reservoir. 
 
4.1.4. Arterial Stiffness Models 
 
After doing extensive research on what types of materials would be best suited to be used as 
arterial models the group felt that the two choices had to be either PTFE tubing or ePTFE or 
expanded PTFE tubing. As seen previously, PTFE and ePTFE have shown some of the best 
promise for being able to mimic the mechanical properties of arteries. Between these two choices 
though, based purely on the newest reseach available, an ePTFE based sample was chosen as the 
group’s initial sample. 
 
 
4.1.5. Arterial Stenotic Models 
 
To create stenotic arterial models, the group devised a system where small inserts would be 
created using a commonly used plumbing caulking. Each plastic insert would be cut open using 
an incision right down the middle of the plastic tubing. Once unrolled, layers of plumbing 
caulking would be applied to the inner lining at the appropriate measured thickness. This insert 
would then be pressed into place within the segments of PTFE tubing. The thickness of the 
caulking layer will be incremented by ~10% per insert until 80% occlusion is reached. The 
preparation of the model is detailed in the Figure 12 below. 
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Figure 23: Occlusion Insert Development 
 
 
4.2. Final Design 
 
As development and manufacturing of our initial design progressed, the group was able to 
conduct preliminary viability testing of the design as a whole, as well as, the components that 
comprise the pulsatile flow generator design. It was apparent upon concluding our initial 
viability testing that many of the components and concepts we had initially developed would 
need to be further refined in order to accurately represent our project aims and objectives. The 
particular components of our system that were further refined were the motor that comprised the 
motion control system, the mounting and structural aspect of our design, tubing, arterial models, 
and lastly the recirculation system. 
 
Initially, we planned to use a wall mounted structural design. With stability remaining a concern 
and aim to strive towards, we found that in the long term our wall mounted design would not 
prove to stand the test of time. In addition, we found that running the system resulting in 
movement and stability issues as a result of the vibrational effects from the motion control 
system. In order to overcome our stability issues as well as to guarantee and increase the shelf 
life of the design, we transitioned from the wall mounted design to a platform mounted design. 
This design allowed us to mount our system to raised aluminum platforms offering greater 
stability, as well as, eliminating any vibrational effects and movement due to the motion control 
system. Lastly, this redesign also afforded to us the capability of adding a retractable base system 
to our mounting design, comprising of one fixed end holding the motion control system and right 
end specimen fixation grip and the retractable end that holds the left end speciment fixation grip 
as well as the start of the recirculation system. This system allows for the testing of samples 
ranging is size from 4 inces to 24 inches. 
 
In addition to redefining the structural aspect of the design, we also transitioned from the non-
transparent PVC tubing to clear Lexan tubing, offering us greater visibility of our system flow. 
The clear tube allowed us to self regulate the flow of the system given the ability to view how 
the flow entered and exited the system and if there were any issues at which location in the 
system did they reside.  
 
48 | P a g e  
 
 
 
Figure 24: Pulsatile Flow Generator CAD Angle View 
 
 
 
Figure 25: Pulsatile Flow Generator CAD Front View 
 
Due to the inability of the group to procure ePTFE and PTFE samples in the varying thicknesses 
and inner diameters that we required from Materials Companies such as GORE and Zeus, we 
were forced to research our other alternatives in more detial. The group went back to some of its 
original ideas such as the use of liquid latex. After further research into the mechanical properties 
of latex, the group felt that the properties provided by the latex would suffice in meeting the 
physiological requirments set forth by the group. Therefore, the group decided that the 
development of our own  latex arterial models would not only be more cost-effective given our 
limited budget but also would give us greater control and customization with the varying arterial 
thicknesses. In addition it would allow us to create novel stenotic models that would be more 
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uniform is compostion and more physiological in morphology with respect to our initial plans of 
using inserts. 
 
The initial recirculation system which comprised of a drill pump system proved to be rather 
laking in safety, as well as, stability and was incapable of meeting the total head requirement of 
10ft which was need to trasnport the blood substitute from the 1st resevoir to the 2nd resvoir in the 
recirculation system. This allowed us to redefine and redesign our recirculation system to a more 
self regulating system and much easily controlled system. With the addition of a submersible 
pump that met our total head requirement of 10ft, we were able to situate the pump within our 1st 
resevoir and have it pump our blood subsitute directly up to the 2nd resevoir offering a more 
closed and controlled system versus the benchtop mounted drill pump. The final design of our 
system can be seen in the figure below. 
 
 
Figure 26: Pulsatile Flow Generator Front View 
 
Figure 27: Pulsatile Flow Generator Angle View 
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4.2.1. Motion Controlled Cardiovascular System 
 
    
 
Figure 28: Pulsatile Flow Generator Motion Control System 
 
The governing principle of our design as a whole was the concept of “as physiological as 
possible”, in that we wanted to guarantee that throughout the entire development process, our 
system stayed true to the physiological cardiac cycle and blood flow in the human body. We had 
to validate that our system indeed replicated the basic components of the cardiac cycle, 
comprised of Early Diastole, Late Diastole, Atrial Diastole, Ventricular Systole. Blood enters the 
heart through the ventricles during atrial systole and as pressure increases, the blood is forced out 
of the chambers through the valves and into the circulatory system. Just as the cardiac cylce 
functions with the inlet and outlet of blood, our system operates in the same manner.  
 
As the motion control system is initiated at the required frequenzy of 1Hz or 60bpm, the piston 
moves backwards causing more fluid to enter the fluid chamber from the constant flowing 
resevoir above. When the piston reaches it desired position it enters the system moveing forward 
at a higher velocity almost at a factor of 10 forcing the fluid into the pulsatile flow system. This 
fluid motion also acts as an artificial valve as it prevents moemntarily the flow of fluid from the 
resevoir above.  
 
The group has assumed the partial flow of fluid back from the system into the chamber following 
the system and the fluid flow up into the inlet from the resevoir as the fluid is forced back into 
the system are neglible. In particular, losses to these two actions are negligible given the minor 
fluid losses we expereience and the fact that it does not disrupt the flow or pressure readings as 
this increased in velocity volume of fluid flows through the system. The cardiac cycle 
representation and accurate replication by our piston pulsatile flow generator can be seen 
detailed in the figure below. 
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Late Diastole Atrial Systole Ventricular Systole Early Diastole
 
Figure 29: Cardiac Cycle Replication 
 
4.2.2. Arterial Stiffness Models 
 
Latex models with varying wall thicknesses were needed to analyze how changes in stiffness 
affected the properties of the pulsatile wave. To develop these samples, polyvinyl chloride 
(PVC) tubes of roughly 15 inches in length and 1 inch inner diameter were loosely attached on 
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both corners using a clamp. The clamps were then attached to ring stands to hold the PVC 
horizontally. A permanent marker (Sharpie, twin tip) was then used to mark a corner of the PVC 
to indicate the starting point.  
 
To create the compliance models, a soft paint brush (12 Royal softgrip S64590) was first dipped 
in warm water to make the bristles softer. The paint brush was then thoroughly dried using paper 
towels, and dipped into the liquid latex (Mold Builder by Castin Craft). Using long strokes from 
one end of the PVC to the other, latex was then evenly brushed over the face. Bands of latex 
were brushed over to minimize streaking as much as possible. The PVC was then slowly rotated 
within the slightly loose clamp to expose a new unpainted face of the PVC. The above steps were 
repeated, where latex was applied, and evenly brushed from one end of the PVC to the other 
using long strokes. While painting the second face, extra attention was given to the interface of 
first and second face. The latex was applied closer to the first face, and the two faces were 
completely blended in order to minimize an uneven interface. These steps were repeated until the 
first and last faces were properly blended.  
 
Once the application was completed and streaks were minimized, one side of the sample was 
blow dried using a blow dryer (Vidal Sassoon) until the latex was partially dried. The PVC was 
then rotated again around its axis to expose a new face. This process continues until all faces of 
the tube were evenly heated to eliminate any deformations that may occur due to uneven drying.  
 
To determine if the latex was sufficiently dried for the next layer to be painted, one edge of the 
latex was touched with bare fingers. If the latex felt in any way liquid, drying was continued. A 
visual means to determine if the latex was wet was by observing the painted layer. If the painted 
area was still white, it was likely to still be wet. A good indication of sufficiently dried latex is 
when the latex turns slightly yellow. However, precautions were taken to prevent the latex from 
completely drying (yellow). This was done in order to ensure that the next layer would evenly 
bond with the previous layer.  
 
Streaks, though minimized, were common in some of the thicker samples. These samples 
required a longer time to sufficiently dry, therefore controlling the streakage became more and 
more difficult as each layer was added.  
 
Each layer was painted with maximum consistency, (that is, amount of latex used) to produce 
roughly incremental increase in wall thickness of the sample with increasing number of layers. 
Once the predetermined number of layers is for each sample had been applied (4, 6, 8, 10, and 12 
layers), the sample was allowed to dry at room temperature for a period of at least 24 hours.  
 
To remove the sample from the PVC, baby powder (Johnson’s) was applied to the outside of the 
sample to minimize friction. Both the edges of the sample were trimmed to remove the 
inconsistent areas using a knife or a sharp blade. One side of the trimmed latex was turned inside 
out, and the sample smoothly slid backwards over the powder. The sample was then turned 
inside out, and trimmed down a length of roughly 9 inches.  
 
To be able to use these models within the pulsatile flow generator, the edges of each sample had 
to be mounted on a small PVC pieces. The edges of each sample were slid over the 1-inch inner 
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diameter PVC tubes and were securely bonded using either a putty (QuickPlastik by Polymeric 
Systems Inc) or glue (Stik’n Seal by Loctite), and allowed to dry for a period of 12-24 hours. 
Once dried, roughly 1 mm holes were drilled as close to the latex-PVC interface as possible. 1-
mm inner diameter tubing was then inserted through the hole roughly ½ inch deep. The 1mm 
inner diameter tube would later be attached to the pressure transducers. Common plumber 
caulking was then applied around the hole on the PVC-tube interface and allowed to dry for 
another 18-24 hours to prevent possible leakage. 
 
 
 
 
 
Figure 30: Arterial Compliance Models 
 
4.2.3. Arterial Stenotic Models 
 
To produce the occlusion models, custom designed metal rods were machined. These metal rods 
each had a point depression about halfway down the rod. It was believed that when painted over 
with latex and slid off, these samples would have a concave going down into the lumen of the 
sample, recreating a physiological occlusion. 
 
To extend the metal rods to a sufficient length, two pieces of 2-in long, 1-in outer diameter PVC 
fittings were tightly secured to the short metal rod using vinyl electrical tape. Initially, the PVC-
Occlusion combination was held horizontally using the clamp-ring stand method mentioned 
above, however, due to the weight of the metal and insufficient strength of the tape, the metal 
piece began to sag and deform the sample. Therefore, the sample was held vertically on a 
wooden board, and latex was applied around the base of the PVC. The latex was allowed to dry 
for a period of 24 hours to secure the sample to the wooden board. Once secured, the occlusion 
model was evenly painted using the method mentioned above.  
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Caulking was later inserted into the occlusion and the sample was again allowed to dry for a 
period of 24 hours. The sample was then bonded to 1-in inner diameter PVC tubing, and drilled 
using a drill press. 1-mm tube was inserted into the sample, and sealant was again applied to 
secure the tube to the PVC. 
 
  
Figure 31: Arterial Stenosis CAD Models 
 
4.3. Design Validation 
 
In order to validate the second design iteration, the group created a few testing methods. Each 
testign method was used to validate a different part of the system from the entire system itsself, 
down to the models being used for testing. 
 
4.3.1. Arterial Models 
 
For the group to validate that the new latex based arterial stiffness and stenosis models would 
provide the group with some physiological properties, the group designed and implemented a 
simple testing system in order to quantify or measure radial compliance and pulse wave velocity. 
By having an understand of the radial compliance and pulse wave velocity of each sample, the 
group would better understand exactly how physiologically similar each testing sample was. 
 
4.3.1.1. Compliance Testing Systems 
 
The group chose to research different types of compliance testing systems in order to analyze the 
radial compliance of each sample and verify their physiological properties. The group studied 
two speicfic systems, The 9100 Series Stent/Graft Testing system produced by Enduratech and 
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the Model SVP216 Vascular Graft and Tube testing system produced by Dynatek Dalta. Both 
these systems provided a very high-tech and accurate way of measuring radial compliance. Also 
both used very precise measuring tools such as laser monitoring to accurately measure both the 
strain on the sample and change in pressure (Enduratech and Dyantek Dalta, 2000). 
 
Using these types of testing devices would be ideal, but with limited funds to actually hire a 
company to perform these tests for us and the unavailability of the device at WPI, the group felt 
that another option would to actually study the design of the devices and devise a way to 
simplify the device into its most important compoenents. 
 
4.3.1.2. Final System 
 
Since the group did not have access to the best resources available for compliance testing, it felt 
there was a need to create a type of test, which could be easily made in the and for a low cost. 
After much research, it was seen that most compliance testing models each contained a way to 
increase the pressure in the sample and a way to measure what the pressure was using a 
manometer of some kind (Enduratech, 2000). 
 
Using this simplification of most test systems the group constructed its compliance testing 
system as seen below in Figure 14. The pump and manometer found at each end of the model 
was taken from a disassembled sphygmomanometer or a common blood pressure cuff. By 
sealing the pump and manometer to there respective bases and attaching the samples in between 
the two bases, the group created a sound, airtight compliance testing model for the purposes of 
this study. 
 
 
Figure 32: Compliance Testing System CAD Model 
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5. Methodology 
 
5.1. Blood Substitute Preparation 
 
As mentioned previously, viscoelasticity plays an important role in flow of blood in a 
physiological setting. That is, the viscous properties of blood due to the plasma and blood cells, 
respectively, are important towards the flow properties of the blood. It has also been shown that 
viscosity directly affects the flow pressures and velocity of the blood in the body, where 
increased viscosity results in increased pressures and lowered velocities. Therefore, to reduce 
pressure deviations due to incorrect fluid properties, the viscosity of our physiological fluid must 
closely mimic the viscosity of blood. 
 
Through clinical research, viscosity of whole blood has been measured to be approximately 4 cP 
(4*10-2 poise) (Anand, 2007). Since glycerin is miscible with water and since glycerin has a very 
high viscosity (15 poise) diluted form of glycerin have most commonly been used as a standard 
to perform tests where viscosity must be taken into account (Elad, et. al., 2003). Previous studies 
have used a 40% glycerin and 60% water solution to measure the physiological effects of 
artificial bloods on various biomedical devices. Since this combination is used in previous 
studies, it is assumed that the combination has a viscosity that closely resembles the viscosity of 
whole blood and would be ideal for our experimentations. 
 
The blood substitute was developed utilizing the following procedure: 
 
1. Measure out 8mL of Glycerin (99% Pure ACS Grade) 
2. Add the 8L of Glycerin to a 20L carboy 
3. Measure out 12L of distilled water 
4. Add the 12L of distilled water to the 20L carboy diluting the Glycerin 
5. Mix the 40% Glycerin – 60% Water solution 
 
5.1.1. Viscosity Testing 
 
Blood viscosity is typically measured utilizing a viscometer. However, due to our limited 
resources and previously allocated budget, the group was forced to perform a falling ball 
viscosity testing methodology on our blood substitute solution. The methodology consisted of 
drawing a sample of the solution from the 20L carboy and into a 2L Nalgene container.  
 
The sample was then heated up with a common hair dryer until it reached a temperature of 37 
°C, which is the temperature at which are documented blood viscosity was measured. Once the 
sample reached a temperature of 37 °C, it was then poured into a graduated cylinder. A 
temperature probe was also inserted into the graduated cylinder in order to allow the group a 
constant observance of the temperature, as well as, to make not of any significant drops in the 
solution temperature in order to not skew the data.  
 
Strips of tape were fixed to the graduated cylinder to serve as markers for our stopwatch. The 
first marker was set at a lower point on the graduated cylinder in order to allow the marble to 
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flow through the fluid for some time and to eliminate some of the acceleration it had built up due 
to the drop. Once the viscosity testing system was established, the group began to drop uniform 
marbles with a weight of down the graduated cylinder, starting our timer as it reached the first 
marker and stopping it as it crossed the second marker. The Δt was then recorded and included in 
our viscosity testing equation. As we completed this analysis we found that the values for our 
experimentally found viscosity were extremely off. Upon further research, values for aqueous 
glycerine solutions were found and our initial assumption of the need to heat our solution to that 
of blood was incorrect. Since literature did not state whether or not those who used this type of 
blood substitute did not heat it up we felt it necessary to do so and guarantee that our values were 
accurate. Thus, we implemented the testing methodology once again but without heating our 
solution to 37 °C but rather testing at a temperature of 21.6 °C. After performing the viscosity 
testing, the group observed that it’s findings were skewed due to the fact that the proper timing 
patterns necessary for proper viscosity analysis were unrealistic. The group felt that there was 
enough evidence in literature to properly validate the use of the 40% aqueous glycerin solution 
as our blood substitute.  
 
The viscosity, as well as, the density of our solution would fall within the physiological viscosity 
range of blood is tested at 21.6° C as can be seen in the table below. 
 
 
Glycerine (%)  Density (g/cm3)  
 25 °C  30 °C  
40  1.09710  1.09475  
Glycerine (%) Viscosity (cP) 
 20 °C  30 °C  
40  3.72  2.72  
Table 9: Properties of Aqueous Glycerine Solutions (The Dow Chemical Company) 
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5.2. Latex Arterial Model Development 
 
5.2.1. Stiffness Model 
 
Latex models with varying wall thicknesses were needed to analyze how changes in stiffness 
affected the properties of the pulsatile wave. To develop these samples, polyvinyl chloride 
(PVC) tubes of roughly 15 inches in length and 1 inch inner diameter were loosely attached on 
both corners using a clamp. The clamps were then attached to ring stands to hold the PVC 
horizontally. A permanent marker (Sharpie, twin tip) was then used to mark a corner of the PVC 
to indicate the starting point.  
 
To create the compliance models, a soft paint brush (12 Royal softgrip S64590) was first dipped 
in warm water to make the bristles softer. The paint brush was then thoroughly dried using paper 
towels, and dipped into the liquid latex (Mold Builder by Castin Craft). Using long strokes from 
one end of the PVC to the other, latex was then evenly brushed over the face. Bands of latex 
were brushed over to minimize streaking as much as possible. The PVC was then slowly rotated 
within the slightly loose clamp to expose a new unpainted face of the PVC. The above steps were 
repeated, where latex was applied, and evenly brushed from one end of the PVC to the other 
using long strokes. While painting the second face, extra attention was given to the interface of 
first and second face. The latex was applied closer to the first face, and the two faces were 
completely blended in order to minimize an uneven interface. These steps were repeated until the 
first and last faces were properly blended.  
 
Once the application was completed and streaks were minimized, one side of the sample was 
blow dried using a blow dryer (Vidal Sassoon) until the latex was partially dried. The PVC was 
then rotated again around its axis to expose a new face. This process continues until all faces of 
the tube were evenly heated to eliminate any deformations that may occur due to uneven drying.  
 
To determine if the latex was sufficiently dried for the next layer to be painted, one edge of the 
latex was touched with bare fingers. If the latex felt in any way liquid, drying was continued. A 
visual means to determine if the latex was wet was by observing the painted layer. If the painted 
area was still white, it was likely to still be wet. A good indication of sufficiently dried latex is 
when the latex turns slightly yellow. However, precautions were taken to prevent the latex from 
completely drying (yellow). This was done in order to ensure that the next layer would evenly 
bond with the previous layer.  
 
Streaks, though minimized, were common in some of the thicker samples. These samples 
required a longer time to sufficiently dry; therefore controlling the development of streaks 
became more and more difficult as each layer was added.  
 
Each layer was painted with maximum consistency, (that is, amount of latex used) to produce 
roughly incremental increase in wall thickness of the sample with increasing number of layers. 
Once the predetermined number of layers is for each sample had been applied (4, 6, 8, 10, and 12 
layers), the sample was allowed to dry at room temperature for a period of at least 24 hours.  
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To remove the sample from the PVC, baby powder (Johnson’s) was applied to the outside of the 
sample to minimize friction. Both the edges of the sample were trimmed to remove the 
inconsistent areas using a knife or a sharp blade. One side of the trimmed latex was turned inside 
out, and the sample smoothly slid backwards over the powder. The sample was then turned 
inside out, and trimmed down a length of roughly 9 inches.  
 
To be able to use these models within the pulsatile flow generator, the edges of each sample had 
to be mounted on a small PVC pieces. The edges of each sample were slid over the 1-inch inner 
diameter PVC tubes and were securely bonded using either a putty (QuickPlastik by Polymeric 
Systems Inc) or glue (Stik’n Seal by Loctite), and allowed to dry for a period of 12-24 hours. 
Once dried, roughly 1 mm holes were drilled as close to the latex-PVC interface as possible. 1-
mm inner diameter tubing was then inserted through the hole roughly ½ inch deep. The 1mm 
inner diameter tube would later be attached to the pressure transducers. Common plumber 
caulking was then applied around the hole on the PVC-tube interface and allowed to dry for 
another 18-24 hours to prevent possible leakage. 
 
5.2.2. Stenosis Model 
 
To produce the occlusion models, custom designed metal rods were machined. These metal rods 
each had a point depression about halfway down the rod. It was believed that when painted over 
with latex and slid off, these samples would have a concave going down into the lumen of the 
sample, recreating a physiological occlusion. 
 
To extend the metal rods to a sufficient length, two pieces of 2-in long, 1-in outer diameter PVC 
fittings were tightly secured to the short metal rod using vinyl electrical tape. Initially, the PVC-
Occlusion combination was held horizontally using the clamp-ring stand method mentioned 
above, however, due to the weight of the metal and insufficient strength of the tape, the metal 
piece began to sag and deform the sample. Therefore, the sample was held vertically on a 
wooden board, and latex was applied around the base of the PVC. The latex was allowed to dry 
for a period of 24 hours to secure the sample to the wooden board. Once secured, the occlusion 
model was evenly painted using the method mentioned above.  
 
Caulking was later inserted into the occlusion and the sample was again allowed to dry for a 
period of 24 hours. The sample was then bonded to 1-in inner diameter PVC tubing, and drilled 
using a drill press. 1-mm tube was inserted into the sample, and sealant was again applied to 
secure the tube to the PVC. 
 
5.3. Arterial Testing 
 
Arterial stiffness testing was performed in order for the group to gain an understanding of the 
mechanical properties of the latex samples used and how those properties compared to the 
mechanical properties of actual human arteries. Two types of testing and analyses were 
performed in order to confirm any results observed. These tests included a compliance test and a 
pulse wave velocity analysis. 
 
5.3.1. Radial Compliance Testing 
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The first type of test performed in order to analyze the stiffness of the samples was a radial 
compliance test.  This type of testing was done as a preparatory step before each sample could be 
tested with the flow generator in order for the group to understand exactly what type of sample 
was being tested. The group felt it was necessary to understand exactly how stiff each sample 
was and using this information, be able to understand for what age range each sample fell into 
with regard to arterial health. 
 
Each sample was tested by attaching it between the two bases, verifying that the system was 
airtight but initiating short pumps and checking for air leaks. Once an airtight system was 
successfully achieved, each sample was pumped up to a pressure of 80mmHg, 90mmHg, 
100mmHg, 110mmHg and 120mmHg. At each pressure point, the new diameter was measured 
using a caliper. This type of testing was performed on each sample three times, although for 
some of the thinner models, testing could not reach the later rounds due to plastic deformation of 
the sample due to high pressure in the system. 
 
5.3.2. Tensile Testing 
 
The second type of analysis performed to observe the amount of stiffness in each sample was a 
pulse wave velocity analysis. Before a pulse wave velocity analysis could be performed though, 
a round of tensile testing needed to be performed in order to calculate the elastic modulus of the 
latex samples used. The elastic modulus was critical value needed to perform the pulse wave 
velocity analysis using the pulse weave equation. Since there was no change in the chemical 
composition of the latex during sample production, the group tested two samples, assuming the 
output curves would be the same for both samples. 
 
As compliance is a measure of wall stiffness, the Tensile Testing method will allow us to analyze 
the slope of the stress strain curve corresponding to a given pressure. Tensile testing will require 
the use of the Instron testing machine, which is available to us through the BME Department. 
The Instron machine can apply either a cyclic or static load. Cyclic loads are normally used to 
see how fatigue will cause failure in a material. Where as static loading applies a single force 
until failure. In this experimentation a static loading of max 10lb is being used due to the fact 
that the group does not wish to analyze the sample until failure, rather just to analyze its curve 
from elastic until plastic deformation. 
 
5.3.3. Pulse Wave Velocity Analysis 
 
Now that the group had an experimentally measured elastic modulus, pulse wave velocity 
analysis could be performed. The analysis was performed using the equation 
 
 Equation 16 
 
)2/(2 hR
Ehc += ρ
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from which the pulse wave analysis will be known. This calculation was performed on each 
sample to be tested. Velocity results were then compared a graph which shows different 
velocities the age ranges that they correspond to. This graph can be seen in Figure 17 (Fung, 1993). 
 
 
Figure 33: Pulse Wave Velocity vs. Mean Blood Pressure (Fung, Biomechanics) 
 
5.4. Pulsatile Flow Generator System Calibration 
 
It was necessary for us to conduct testing of our arterial samples under physiological conditions. 
Since the inception of our research project, developing our system as physiological as possible 
was a big issue and can be seen through the creation of our blood substitute and the development 
of our physiological arterial samples.  
 
The last parameter for us in order to test under physiological conditions was establishing and 
maintaining a physiological blood pressure of (75 – 80mmHg). In a controlled experiment, the 
impedance would have to be created in order to mimic the physiological impedance found in the 
body. Most prior academic studies at WPI and some within industry used some type of check 
valve to build up that pressure in the system. In order to achieve this, the group employed the use 
of two ball valves, one controlling the flow into the system and the other controlling the flow 
exiting the system. We were able to reach and maintain a physiological pressure of 76mmHg for 
all testing conducted adhering to the following methodology. 
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1. Open all valves 
2. Turn on the recirculation system and fill up the reservoir 
3. Allow the system to circulate until the reservoir has been filled 
4. Set the outflow valve to its designated position 
5. Allow a column of the solution to fill the tubing 
6. Unlock the Piston Motor control and use the piston to raise the fluid column into the 
reservoir establishing a uniform system pressure 
7. Lock and set the piston to its position 
 
5.4.1. Pulse Wave Development & Calibration 
 
In order to calibrate the system, it was necessary to first complete phasing of the motor utilizing 
the ProMOTION software that was provided to us with the ION Digital Drive. The piston load is 
disconnected from the motor and Phasing is Initialzed. 
 
 
Figure 34: Phase Initialization Parameters 
 
 
Motion Control Code was developed using SDIEdit in order to produce the Common Iliac 
Pressure waveform which we were aiming for. The code consists primarily of the intial P.I.D. 
parameters and Current Loop values that were estimated using the ProMOTION software.  
 
 
Figure 35: Current Loop Parameters 
 
The last portion of the code is the actual piston control language and is coded as a “while” loop 
with particular attention to the inlet and outlet velocities which control the development of the 
amplitude and wavelength of our pressure waveforms in conjunction with the PID parameters. 
cs PMDOPSetCurrentControlMode, 1 
cs2 PMDOPSetFOC, 0, 300 
cs2 PMDOPSetFOC, 1, 300 
cs2 PMDOPSetFOC, 2, 32767 
cs2 PMDOPSetFOC, 256, 300 
cs2 PMDOPSetFOC, 257, 300 
cs2 PMDOPSetFOC, 258, 32767 
cs2 PMDOPSetCurrentLoop, 0, 500 
cs2 PMDOPSetCurrentLoop, 1, 500 
cs2 PMDOPSetCurrentLoop, 2, 32766 
cs2 PMDOPSetCurrentLoop, 256, 500 
cs2 PMDOPSetCurrentLoop, 257, 500 
cs2 PMDOPSetCurrentLoop, 258, 32766 
cs2 PMDOPSetHoldingCurrent, 0, 32767 
cs2 PMDOPSetHoldingCurrent, 1, 32767
cs PMDOPSetCaptureSource, 0 
cs PMDOPSetPhaseCounts, 2000 
cs PMDOPSetCommutationMode, 0 
cs PMDOPSetPhaseCorrectionMode, 0 
cs PMDOPSetPhaseInitializeMode, 1 
cs PMDOPSetPhaseInitializeTime, 0 
cs PMDOPSetPhasePrescale, 0 
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Figure 36: Waveform Morphology Code 
 
There are two ways of adjusting the P.I.D. gains in order to produce the waveform we are aiming 
for, utilizing a trial and error methodology or an analytical approach. Given the difficult in trying 
the to calculate the relative gains that were necessary to produce a waveform close to the 
common iliac artery pressure waveform and our diminishing timeframe, the group took the route 
of manually adjusting the gains through trial and error. In order to do so, the system it was 
necessary for the system to be fully running and outputting pressure readings. The following 
methodology was followed. 
 
1. Set Ki and Kd to “0” 
2. Slowly increase Kp the motor shaft oscillates 
3. Increase Kd until the necessary amplitude is observed. 
4. Record the value of Kp and Kd 
5. Increase/Decrease Kd as necessary 
While (x > -1) 
pause 400 
cs PMDOPResetEventStatus, &h0000 
cs PMDOPSetVelocity, 66847 
cs PMDOPSetPosition, 0 
pause 000 
cs PMDOPUpdate, 0 
pause 500 
cs PMDOPResetEventStatus, &h0000 
cs PMDOPSetVelocity, 6684 
cs PMDOPSetPosition, 1000 
pause 000 
cs PMDOPUpdate, 0 
x = x+1 
Wend
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6. Results 
6.1. Piston Slider Crank Analysis         
Table 10: Kinematic Analysis 
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6.2. Arterial Testing 
6.2.1. Radial Compliance Testing 
 
Once all of the testing was completed, the data collected was used to calculate the radial 
compliance of each sample. Since three rounds of testing were performed on each sample, an 
average of the radial compliances of each round was used as the final result. Table 8 below 
shows the complete data analysis spreadsheet from the radial compliance testing including the 
average radial compliances. The calculation of these radial compliances were done using the 
following equation 
  
⎟⎠
⎞⎜⎝
⎛ Δ= 100100 x
P
x
Ri
RC   Equation 17 
 
As a secondary compliance analysis, the group also used the same results from the compliance 
testing and calculated compliances using the following equation as well 
 
⎟⎠
⎞⎜⎝
⎛
Δ
Δ=
P
RC     Equation 18 
 
The results of which can be seen below in Table 9 below: 
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Expansion of Radius Due to Pressure 
±0.001     Radial Compliance     
             
Round 1             
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg  
             %   %   %  
4 layers 13.99 0.550 0.6005 0.6000 n/a  12.60 11.17 20.01 18.20 n/a  
6 layers n/a n/a n/a n/a n/a  n/a n/a n/a n/a n/a  
8 layers 0.55 0.6000 0.6001 0.6001 0.6505  12.5 22.23 20.01 18.20 25.08  
10 layers 0.501 0.5501 0.5500 0.6001 0.6000  0.25 11.12 10.00 18.18 16.67  
12 layers 0.5505 0.6000 0.6001 0.6500 0.6502  12.61 22.31 20.02 27.27 25.03  
                   
             
Round 2             
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg  
             %   %   %  
4 layers n/a n/a n/a n/a n/a  n/a n/a n/a n/a n/a  
6 layers n/a n/a n/a n/a n/a  n/a n/a n/a n/a n/a  
8 layers 0.5500 0.6000 0.6001 0.6002 0.6502  12.51 22.23 20.02 18.20 25.03  
10 layers 0.5006 0.5501 0.6000 0.6000 0.6000  0.15 11.12 20.00 18.18 16.67  
12 layers 0.5501 0.6001 0.6001 0.6002 0.6002  12.51 22.30 20.01 18.21 16.69  
             
Round 3             
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg  
             %   %   %  
4 layers n/a n/a n/a n/a n/a  n/a n/a n/a n/a n/a  
6 layers n/a n/a n/a n/a n/a  n/a n/a n/a n/a n/a  
8 layers 0.5501 0.6001 0.6001 0.6000 0.6504  12.51 22.23 20.01 18.19 25.07  
10 layers 0.5001 0.5500 0.6000 0.6000 0.60045  0.0188 11.11 20.00 18.18 16.74  
12 layers 0.5501 0.600475 0.60005 0.650005 0.6000  12.53 22.32 20.01 27.27 16.67  
             
Average Percent Radial Compliance           
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg        
4 layers 12.59 11.18 20.01 18.20 n/a        
6 layers n/a n/a n/a n/a n/a        
8 layers 12.51 22.23 20.02 18.20 25.10        
10 layers 0.1395 11.12 16.67 18.18 16.70        
12 layers 12.55 22.31 13.34 15.16 13.90       
Table 11: Radial Compliance Analysis
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 Testing Round 1        
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg        
Test Sample Recorded ( r )        
4 layers 1.398 1.398 1.524 1.524. N/A        
6 layers N/A N/A N/A N/A N/A        
8 layers 1.397 1.524. 1.524. 1.524. 1.652.        
10 layers 1.272. 1.397. 1.397 1.524 1.524        
12 layers 1.398 1.525 1.524 1.651 1.651        
             
             
 Testing Round 1   Testing Round 1 
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg   80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
Test Sample Δr  Test Sample Compliance 
4 layers 0.1279 0.1277 0.2541 0.2542 N/A  4 layers 0.0016 0.00142 0.002541 0.002311 N/A 
6 layers N/A N/A N/A N/A N/A  6 layers N/A N/A N/A N/A N/A 
8 layers 0.127 0.254 0.2541 0.2542 0.3828  8 layers 0.0015 0.0028 0.0025 0.0023 0.0031 
10 layers 0.0025 0.1272 0.1271 0.2545 0.2547  10 layers 3.17E-05 0.0014 0.00127 0.0023 0.0021 
12 layers 0.1283 0.2551 0.2544 0.3816 0.3813  12 layers 0.0016 0.0028 0.0025 0.0034 0.0031 
ΔP 80 90 100 110 120        
             
 Testing Round 2        
 80mmHg 90mmHg 100mmHg 110mmHg 120mmHg        
Test Sample Recorded ( r )        
4 layers N/A N/A N/A N/A N/A        
6 layers N/A N/A N/A N/A N/A        
8 layers 1.3974 1.5244 1.5244 1.5241 1.658        
10 layers 1.2714 1.3971 1.5249 1.5245 1.5244        
12 layers 1.3977 1.5243 1.5241 1.5248 1.5295        
             
             
 Testing Round 2   Testing Round 2 
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg   80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
Test Sample Δr  Test Sample Compliance 
4 layers N/A N/A N/A N/A N/A  4 layers N/A N/A N/A N/A N/A 
6 layers N/A N/A N/A N/A N/A  6 layers N/A N/A N/A N/A N/A 
8 layers 0.1274 0.2544 0.2544 0.2541 0.3118  8 layers 0.0015 0.0028 0.0025 0.0023 0.0031 
10 layers 0.0014 0.1271 0.2549 0.2545 0.2544  10 layers 1.91E-05 0.0014 0.0025 0.0023 0.0021 
12 layers 0.1277 0.2553 0.2541 0.2548 0.2545  12 layers 0.0015 0.0028 0.00254 0.0023 0.0021 
ΔP 80 90 100 110 120        
 
 
 
 
 
Table 12: Compliance Analysis using dr/dP 
 
 
 
 
 Testing Round 3 
 80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
Test Sample Recorded ( r ) 
 4 layers N/A N/A N/A N/A N/A 
6 layers N/A N/A N/A N/A N/A 
8 layers 1.3922 1.5243 1.5291 1.5241 1.6521 
10 layers 1.2701 1.3972 1.5241 1.5248 1.5253 
12 layers 1.3974 1.5207 1.5247 1.6513 1.5243 
      
      
 Testing Round 3 
  80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
Test Sample Δr 
4 layers N/A N/A N/A N/A N/A 
6 layers N/A N/A N/A N/A N/A 
8 layers 0.1272 0.254113 0.254191 0.254081 0.382041 
10 layers 0.0019 0.127032 0.2541 0.2548 0.2543 
12 layers 0.1274 0.2507 0.2547 0.3813 0.2543 
ΔP 80 90 100 110 120 
 Testing Round 3 
 80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
Test Sample Compliance 
4 layers N/A N/A N/A N/A N/A 
6 layers N/A N/A N/A N/A N/A 
8 layers 0.0015 0.0028 0.0025 0.002 0.0031 
10 layers 2.38E-06 0.0014 0.0025 0.0023 0.0021 
12 layers 0.0015 0.0028 0.0025 0.0034 0.0021 
 Average Compliance 
 80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
Test Sample   
4 layers 0.0016 0.00142 0.002541 0.002311 N/A 
6 layers N/A N/A N/A N/A N/A 
8 layers 0.0015 0.0028 0.0025 0.0023 0.0031 
10 layers 1.77E-05 0.0014 0.0021 0.0023 0.00024 
12 layers 0.0014 0.0024 0.0022 0.0030 0.0024 
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6.2.2. Tensile Testing 
 
The results and data points from the tensile testing were recorded and viewed using the Labview 
software program. The subsequent curve created by the recorded data points were then analyzed 
by the group using Microsoft Excel. From the time and force data points present, the group 
calculated the stress and the strain at each data point, thereby producing a stress-strain curve for 
the sample tested as seen in Figure 18. From this curve, the group calculated the elastic modulus 
of the latex which was found to be 2434.60. 
 
Stress vs Strain
y = 2434.6x + 26.691
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Figure 37: Arterial Model Elastic Modulus Analysis 
  
 
6.2.3. Pulse Wave Velocity Analysis 
 
Once the Young’s Modulus was found, the group calculated the pulse wave velocity of each 
sample to be tested. The results of the pulse wave velocity calculations can be seen below in 
Table 10.  
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Pulse-wave Velocity Elastic Modulus Radius Density of Air 
Density of 
Water 
Density of 
Blood Thickness         
c = cm/s E = P = (kg/m*s²)*100 = kg/cm*s² R = cm 
ρ = 
kg/cm³ ρ = kg/cm³ ρ = kg/cm³ h = cm         
  2.43E+03   1.20E-06 1.00E-03 1.05E-03   
        
               
                    Pulse Wave Velocity 
Elastic Modulus Density of Blood 80mmHg 90mmHg 100mmHg 110mmHg 120mmHg Thickness Thickness  Test Sample 80mmHg 90mmHg 100mmHg 110mmHg 120mmHg 
E = P = (kg/m*s²)*100 = 
kg/cm*s² ρ = kg/cm³ R  (h) (h/2)   c = cm/s 
2.43E+03 1.05E-03 1.40 1.53 1.52 1.61 1.57 0.14 0.07 L12-3 327.43 314.04 314.13 306.10 310.02 
2.43E+03 1.05E-03 1.40 1.53 1.52 1.61 1.57 0.14 0.07 L12-1-1 334.26 320.62 320.71 312.52 316.52 
2.43E+03 1.05E-03 1.40 1.53 1.52 1.61 1.57 0.11 0.06 L12-2 297.92 285.65 285.73 278.36 281.96 
2.43E+03 1.05E-03 1.40 1.53 1.52 1.61 1.57 0.15 0.07 L12-1-2 342.29 328.36 328.45 320.08 324.17 
2.43E+03 1.05E-03 1.40 1.53 1.52 1.61 1.57 0.09 0.04 L10-2 268.22 257.09 257.17 250.49 253.75 
2.43E+03 1.05E-03 1.27 1.40 1.48 1.52 1.52 0.11 0.05 L10-3 308.04 294.39 286.17 282.31 282.27 
2.43E+03 1.05E-03 1.27 1.40 1.48 1.52 1.52 0.09 0.04 L10-3 279.26 266.80 259.30 255.78 255.74 
2.43E+03 1.05E-03 1.40 1.52 1.52 1.52 1.65 0.08 0.04 L8-2 259.76 249.00 248.99 248.99 239.42 
2.43E+03 1.05E-03 1.40 1.52 1.52 1.52 1.65 0.11 0.06 L8-1 298.61 286.35 286.34 286.34 275.43 
2.43E+03 1.05E-03 Need Data 
Need 
Data Need Data Need Data Need Data 0.12 0.06 L7-7 
Need 
Data 
Need 
Data Need Data Need Data Need Data 
2.43E+03 1.05E-03 N/A N/A N/A N/A N/A 0.07 0.04 L6-3 N/A N/A N/A N/A N/A 
2.43E+03 1.05E-03 N/A N/A N/A N/A N/A 0.06 0.03 L6-2 N/A N/A N/A N/A N/A 
2.43E+03 1.05E-03 N/A N/A N/A N/A N/A 0.12 0.06 L6-1 N/A N/A N/A N/A N/A 
2.43E+03 1.05E-03 1.40 1.40 1.52 1.52 N/A 0.04 0.02 L4-2 178.60 178.61 171.15 171.14 N/A 
2.43E+03 1.05E-03 1.40 1.40 1.52 1.52 N/A 0.07 0.04 L4-3 242.49 242.51 232.48 232.48 N/A 
2.43E+03 1.05E-03 1.40 1.40 1.52 1.52 N/A 0.09 0.04 L10-4 265.99 266.01 255.07 255.06 N/A 
2.43E+03 1.05E-03 Need Data 
Need 
Data Need Data Need Data Need Data 0.07 0.04 L3-1 
Need 
Data 
Need 
Data Need Data Need Data Need Data 
 
Table 13: Pulse Wave Velocity Analysis 
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6.3. Pulsatile Flow Pressure Waveform Analysis 
 
 
  Heart Rate 2nd Harmonic 3rd Harmonic 4th Harmonic 5th Harmonic 
Sample Hz Amplitude Hz Amplitude Hz Amplitude Hz Amplitude Hz Amplitude 
6_3 0.84229 0.94776 1.67236 0.63569 2.51465 0.26545 3.34473 0.18142 4.99268 0.06417 
8_2 0.84229 0.87093 1.67236 0.30739 2.51465 0.13662 3.33252 0.11032 4.1748 0.05038 
8_3 0.83008 0.84938 1.67236 0.36285 2.50244 0.19675 3.33252 0.16183 4.1626 0.07816 
10_2 0.83008 1.08453 1.67236 0.46822 2.50244 0.2265 3.34473 0.15682 4.1748 0.09716 
12_1_1 0.83008 1.12919 1.67236 1.07001 2.50244 0.49722 3.33252 0.35988 4.1748 0.21018 
12_1_2_2 0.84229 0.80211 1.67236 0.26299 2.50244 0.10705 3.34473 0.06028 4.1748 0.0243 
12_3 0.83008 0.84938 1.67236 0.36285 2.50244 0.19675 3.33252 0.16183 4.1626 0.07816 
                      
2_8occlusion 1.0376 1.25732 2.0752 1.12179 3.11279 0.37831 4.15039 0.25576 5.18799 0.18727 
3_8occlusion 1.0376 1.15032 2.0752 1.34647 3.11279 0.40528 4.15039 0.41224 5.18799 0.1774 
4_8occlusion 1.0376 1.15032 2.0752 1.34647 3.11279 0.40528 4.15039 0.31224 5.18799 0.17174 
4_8occlusion 1.0376 1.26615 2.0752 1.19114 3.125 0.35123 4.1626 0.27581 5.2002 0.19099 
6_8occlusion 1.0376 1.30622 2.0752 0.82445 3.11279 0.27387 4.15039 0.22507 5.18799 0.14848 
Table 14: Frequency & Harmonic Analysis for Stiffness & Occlusion Models 
 
The stiffness model results were comparable for the heart rate magnitudes where the range was is 
0.80211-1.12919 mmHg. When the harmonics were increased from 2 to 5 the magnitudes of the 
harmonics decreased. Take 6-3 for example, the first harmonic has a value of 0.94776 mmHg, 
the second harmonic is 0.63569 mmHg, the third harmonic is 0.26545 mmHg, the fourth 
harmonic is 0.18142 mmHg, and the fifth harmonic is 0.06417 mmHg. Another tread of the 
stiffness data is for the thicker layers the second, third, fourth and fifth harmonics are smaller 
than that of those thinner layers. Sample 8_2 in comparison to 6_3 the second and third harmonic 
are about half the value that of the 6_3 sample. 
 
The occlusion model results also show comparable magnitudes for the first harmonic ranging 
from 1.15032-1.30622 mmHg. A trend that is seen in this data set is that the second harmonic 
has a high value and sometimes surpasses the value of the first, then the third and fourth 
harmonic drop in magnitude value in comparison to the first two harmonics. 
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7. Analysis and Discussion 
 
Upon completion of our testing and the successful collection of our pulsatile flow waveform data 
we were able to compare the variance between our data sets as our arterial models progressed 
from healthy arterial models to diseased and stenotic arterial models. Utilizing Microsoft Excel 
and some statistical tests, the group was able to extract meaningful data from the FFT analysis 
we previously conducted on our pulsatile flow waveforms.  
 
7.1. Arterial Testing 
 
Both compliance and pulse wave velocity analysis showed that the latex arterial models created 
by the group fell within the compliance levels for a healthy young human being. As seen in 
Figure 33, the 8 layer arterial sample would fall into the compliance range for a 16-20 year old 
while the 12 layer would fall within the 20-24 year old range. This validation provided the group 
with enough evidence that the latex models used provided enough physiological properties to 
make the pressure wave data collected from each sample relevant. 
 
 
7.2. Harmonic Statistical Analysis 
 
In order to verify harmonic relevance and determine if any trends can be seen between 
harmonics of both normal and occluded models, the group performed a series of t-tests 
comparing not only normal harmonics but also occluded sample harmonics. Since atherosclerosis 
progresses with increased hypertension, the group theorizes that the amplitude for the occluded 
sample harmonics should be higher than those of the normal samples due to the changes in 
morphology. 
 
Each table below represent a paired t-test of unequal variances. The first set of tables is for the 
Stiffness Models where the second to the fifth harmonic were compared to that of the first. What 
is seen is that for an alpha of 0.05, which means that after analyzing the data the confidence level 
that the data is actually different is 90%, is that the second to the fifth harmonics are statistically 
different for the first. Harmonic one in comparison to harmonic three is p= 5.27 x 10-6 < t-
critical= 2.228. When analyzing the statistical data for harmonics one versus two the p= 0.0116 
<t-critical= 2.36. 
 
 
Stiffness Harmonic 1 vs. 2   
t-Test: Two-Sample Assuming Unequal Variances   
   
 0.94776 0.63569 
Mean 0.93092 0.472385 
Variance 0.019279 0.090448 
P(T<=t) two-tail 0.011588  
t Critical two-tail 2.364624  
Table 15: Stiffness Harmonic 1 vs. 2 
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Stiffness Harmonic 1 vs. 3   
t-Test: Two-Sample Assuming Unequal Variances   
   
 0.94776 0.26545 
Mean 0.93092 0.226815 
Variance 0.019279 0.019481 
P(T<=t) two-tail 5.27E-06  
t Critical two-tail 2.228139  
Table 16: Stiffness Harmonic 1 vs. 3 
 
Stiffness Harmonic 1 vs. 4   
t-Test: Two-Sample Assuming Unequal Variances   
   
 0.94776 0.18142 
Mean 0.93092 0.168493 
Variance 0.019279 0.01039 
P(T<=t) two-tail 1.82E-06  
t Critical two-tail 2.262157  
Table 17: Stiffness Harmonic 1 vs. 4 
 
Stiffness Harmonic 1 vs. 5   
t-Test: Two-Sample Assuming Unequal Variances   
   
 0.94776 0.06417 
Mean 0.93092 0.089723 
Variance 0.019279 0.004132 
P(T<=t) two-tail 2.92E-06  
t Critical two-tail 2.364624  
Table 18: Stiffness Harmonic 1 vs. 5 
 
 
Also seen is that the amplitude for harmonic two is 68.2% of the first harmonic while harmonic 
three is 24.4% of the first. The magnitude of the fourth harmonic is 18.1% of the first. And lastly 
the fifth harmonic magnitude is 9.6% of the first harmonic. 
 
Likewise these similar paired t-tests are statistically significant for occluded models. The p-value 
of occlusion harmonic one verses harmonic two is 0.766 which is less than the t-critical value of 
2.776, meaning that the data is statistically different. 
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Occlusion harmonic 1 vs. 2   
t-Test: Two-Sample Assuming Unequal Variances   
   
 1.25732 1.12179 
Mean 1.218253 1.177133 
Variance 0.006421 0.060644 
P(T<=t) two-tail 0.766699  
t Critical two-tail 2.776445  
Table 19: Occlusion harmonic 1 vs. 2 
 
 
 
 
Occlusion harmonic 1 vs. 3   
t-Test: Two-Sample Assuming Unequal Variances   
   
 1.25732 0.37831 
Mean 1.218253 0.358915 
Variance 0.006421 0.003864 
P(T<=t) two-tail 2.7E-06  
t Critical two-tail 2.446912  
Table 20: Occlusion harmonic 1 vs. 3 
 
 
 
 
Occlusion Harmonic 1 vs. 4   
t-Test: Two-Sample Assuming Unequal Variances   
   
 1.25732 0.25576 
Mean 1.218253 0.30634 
Variance 0.006421 0.006262 
P(T<=t) two-tail 3.53E-06  
t Critical two-tail 2.446912  
Table 21: Occlusion Harmonic 1 vs. 4 
 
 
74 | P a g e  
 
Occlusion harmonic 1 vs. 5   
t-Test: Two-Sample Assuming Unequal Variances   
   
 1.25732 0.18727 
Mean 1.218253 0.172153 
Variance 0.006421 0.000314 
P(T<=t) two-tail 0.000132  
t Critical two-tail 3.182446  
Table 22: Occlusion harmonic 1 vs. 5 
 
For the occluded models, the group observed is that the second harmonic is 96.6% of the first 
harmonic magnitude, whereas the third harmonic is 29.5% of the first, which is similar to what is 
seen in the stiffness models. The fourth harmonic magnitude is found to be 21.0% of the first 
harmonic and lastly the fifth harmonic in comparison to the first harmonic magnitude is 14.1% of 
the first harmonic. These statistical analyses show that there are at least 5 clear and statistically 
different harmonics which can be observed from the FFT analysis meaning that the flow 
generator is capable of producing pressure waves containing 5 clear harmonics. In most instances 
though, more than 5 were actually observed. 
 
The next set of data presents t-tests performed to compare the range of harmonics 1-5 of a 
control sample to harmonics 1-5 of each occlusion sample. The harmonics analyzed were taken 
from the FFT analysis of the entire data set containing 60 pulse waves. The control sample for 
the basis of this statistical analysis is sample 8_3. This sample was chosen because of its 
similarity to a normal healthy artery based on waveform observations and pulse wave velocity 
analysis.  
 
Unoccluded Sample Harmonic 1-5 
vs. Occlusion Models             
t-Test: Paired Two Sample for Means             
  8_3-Control 2/8 in 3/8 in 4/8 in 4/8 in dbl 6/8 in dbl 
  Variable 1 Variable 2 Variable 2 Variable 2 Variable 2 Variable 2 
Mean 0.330 0.640 0.698 0.677 0.655 0.556 
Variance 0.095 0.259 0.266 0.284 0.278 0.248 
Observations 5.000 5.000 5.000 5.000 5.000 5.000 
Pearson Correlation   0.877 0.746 0.750 0.855 0.969 
Hypothesized Mean Difference   0.000 0.000 0.000 0.000 0.000 
df   4.000 4.000 4.000 4.000 4.000 
t Stat   -2.474 -2.343 -2.135 -2.359 -2.369 
P(T<=t) one-tail   0.034 0.040 0.050 0.039 0.038 
t Critical one-tail   2.132 2.132 2.132 2.132 2.132 
P(T<=t) two-tail   0.069 0.079 0.100 0.078 0.077 
t Critical two-tail   2.776 2.776 2.776 2.776 2.776 
 
Table 23: Control Sample vs. Occluded Samples t-test Analysis 
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In Table 23 the comparison of a control sample to the occlusion samples. shows that there is a 
statistical difference between the harmonics of the waveforms for both the unoccluded and 
occluded models. There is also a difference in the means, where the occlusion model is about 
twice that of the control model. The amplitude values found were taken from the  FFT analysis 
of the entire data set. The group performed this initial test in order to observe whether at this 
larger scale that any variances can be observed. 
 
The group observed that there is a statistical difference between the occlusion models and the 
control model with respect to amplitude height as the p-value for each test is much less than the 
t-critical value. This can be especially seen when comparing occluded samples 2/8 in, 3/8 in and 
4/8 in. Since all of these occlusion samples were composed of a one-sided occlusion, with 4/8 
being the most occluded, the group’s theory that the p-value would probably increase was 
verified. As can be seen above the p-values for these three samples went from 0.069 for a 2/8 in 
occlusion model to 0.100 for a 4/8 in occlusion model. Since there is more of an occlusion and a 
higher amplitude, this increase in p-values is consistent with the groups hypothesis that with 
more of an occlusion, amplitude would be higer. 
 
The group was not able to observe any other relevant trends within the p-values for each t-test. 
The group feels that these type of trends would probably need more data point acquisition in 
order to be relevant. 
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8. Conclusions 
 
The group was able to conlude from the study that it was succesful in developing a pulsatile flow 
generator which could create physiological arterial pressure waves. The group was succesful in 
replicating pressure waves within a physiological range of 60mmHg – 120mmHg at a frequency 
of 1Hz or 60 bpm. The motion control device implemented within the system allowed the group 
the needed variability to emulate pressure waveforms corresponding to various locations on the 
arterial tree. 
 
The group was also able to conlude that by creating a physiologically similar environment within 
the system, that the analysis gained from the flow generator would become clinically relevant. 
With the incorporation and use of a physiologically similar blood substitute and physiologically 
similar arterial models, the group was able to produce relevant and useful data. 
 
Furthermore, the group was able to conclude that through statistical analysis performed on 
harmonic amplitude heights, that the pressure waves observed within the occlusion models used 
were statiscially different than the normal stiffness models within a confidence level of 90%. 
Meaning that the initial testing results were succesful in identifying differences between the 
waveforms observed within a normal arterial model and that of a occlusion model. A trend 
noticed by the group throughout the analysis was that the mean for the occlusion models was 
always about twice as much as for the control model meaning that each occlusion model had a 
higher harmonic amplitude than that of the control.  
 
This along with the difference in p-values tells the group that there is statistical difference 
between the harmonics for the occlusion models and those for the control for the entire data 
range. The group was able to observe that with an increase in stenosis, the harmonic amplitudes 
increased significantly over the first two harmonics and drastically decline onwards. This 
indicates that the most relevant information for the the possible early detection of arterial disease 
would be contained within the first two harmonics. This could lead to further findings in the 
hopes of identifying the stage of progression. An example of this can be seen in Table 14 when 
comparing the harmonics of the control sample with that of the 2/8 or 25% occluded sample. It 
was seen that there was a doubling of mean for the amplitude values of harmonic 1-5. Also it 
was seen that there there was an increase in amplitude value between the first and second 
harmonics of the two samples and then a drastic dropoff of ~60%. 
 
The acquisition of this relevant data further validates the group’s success in building a fully 
functional pulsatile flow genrator capable of emulating physiological pressure waveforms. The 
ability of the device to aid in further data acqusition can hopefully someday lead to data which 
could eventually be used to further analyze pressure waveform variances in the hopes of one day 
aiding in the early detection of arterial disease. 
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VII. Recommendations  
 
Although the group feels confident that the findings of the study provide new insight into the 
possible early detection of arterial disease, there are still ways to improve the study and testing 
system. 
 
For future iterations of this type of study the group recommends that within the system itself, 
there should be upgrades in the following areas; pressure transducers and valve control. The 
group feels that if the data acquried from this type of study were to eventually be used clinically, 
more precise pressure transducers need to be used, possibly ones that can be imbedded into the 
tubing system in order to gain a more accurate description of the wave being produced. 
 
Valve control is also an area where there can be improvement. The group used simple ball valves 
to build up and control the pressure within the system manually. The group recommends that for 
future iterations, a more advanced valve control system be implemented such as an automated 
control system where by the openings and closings of the valve could be controlled through a 
device of some kind and not manually. Also with another type of valve system that can be 
implemented involves ones which allow for a known incremental increase or decrease in opening 
space. Instead of relying on human touch to estimate the emount of closure, some kind of 
marking device would allow for greater efficiency and pressure control. 
 
Another recommendation the group has for future iterations is that testing be completed on a set 
of physiological arteries, such as those from an animal. Although the latex models served as 
satisfactory models for this study, the group feels that if the reults of this type of study are to ever 
be used clinically, the testing would need to be completed on animal arteries and eventually 
human arteries. However this would also mean that the system would have top be scaled down 
since arteries do not have 1 inch inner diameters. With a higher budget, research teams down the 
line could scale-down the system, while still using the same motor and motion control system. 
Upon scaling down the system, a novel fixation system must be developed for practical use with 
the physiological samples which would fall in a lumen size of about 6mm. This novel fixation 
system would replace the PVC grip fixation system the group is currently utilizing giving our 
scaled up models. 
 
The final recommendation the group has for future iterations of this type of project is that more 
data aqcuistion should be undertaken. Although the group felt it was succesful in observing 
statistical differences between the harmonics of the occlusion models compared to those of 
normal models, in order for the data to be more relevant, much more testing needs to be 
performed. The use of different types of models, or the addition of more data points may allow 
for further insight into trends that may occur between occlusion and normal arterial models. 
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IX. Nomenclature 
 
 
 
µ, η Fluid Viscosity cP 
   
E Elastic Modulus GPa 
   
σ Stress GPa 
   
ε Strain cm/cm 
   
C Compliance cm/s 
   
τ Shear Stress kg/cm³ 
   
P Pressure mmHg 
   
R Radius cm 
   
D Diameter cm 
   
Q Flow Rate cm³/s 
   
A Area cm2 
   
ρ Fluid Density kg/cm³ 
   
l Length cm 
   
h Wall Thickness cm 
   
ai Point Radius cm 
   
c0 Pulse Wave Velocity cm/s 
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X. Appendices 
Appendix A: Piston Slider-Crank Kinematic Analysis 
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Appendix B: Pulsatile Flow Pressure Waveforms 
 
Arterial Model #6_3 – Thickness = .07cm 
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Arterial Model #8_2 – Thickness = .08cm 
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Arterial Model #8_3 – Thickness = .08cm 
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Arterial Model #10_2 – Thickness = .09cm 
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Arterial Model #10_3 – Thickness = .11cm 
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Arterial Model #12_1_1 – Thickness = .14cm 
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Arterial Model #12_1_2 – Thickness = .15cm 
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Arterial Model #3_8ths Occlusion 
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Arterial Model #4_8ths Double Occlusion 
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Arterial Model #6_8ths Double Occlusion 
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Appendix C: Pressure Waveform Fast Fourier Analysis 
 
Arterial Model #8_2  – FFT 
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Arterial Model #8_3 – FFT 
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Arterial Model #10_2 – FFT 
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Arterial Model #10_3 – FFT 
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Arterial Model #12_1_1 – FFT 
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Arterial Model #12_1_2 – FFT 
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Arterial Model #2_8ths Occlusion FFT 
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Arterial Model #3_8ths Occlusion FFT 
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Arterial Model #4_8ths Occlusion FFT 
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Arterial Model #4_8ths Double Occlusion FFT 
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Arterial Model #6_8ths Double Occlusion FFT 
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Arterial Model #6_3 – FFT 
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Appendix D: ION Digital Drive 
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Appendix E: Piston CAD Drawing 
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Appendix F: Connecting Rod CAD Drawing 
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Appendix G: DC Motor Specifications 
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Appendix H: Pressure Transducer Specifications 
 
 
 
Figure 8: BIOPAC Pressure Transducer 
 
BIOPAC SS13L Pressure Transducer 
Operational Pressure: -50 mmHg to 300 mmHg 
Overpressure: -400 to + 4000 mmHg 
Dynamic response: 100 Hz 
Transducer Dimensions: 67mm long, 25mm wide 
Weight: 11.5 grams 
Unbalance: 50 mmHg max 
Connection ports: Male Luer (2) 
Eight hour drift: 1 mmHg after 5 minute warm-up 
Isolation: <= 5 µA leakage at 120 VAC/60 
Hz 
Defibrillation: Withstands 5 discharges of 400 
joules in 5 minutes across a load 
Operating Temperature: + 15 to + 40 °C 
Storage Temperature: -30 to + 60 °C 
Combined effects of sensitivity linearity and 
hysteresis: 
1 mmHg (nominal) 
Output: 5 µV/mmHg (normalized to 
1Vexcitation) 
Cable Length: 2 meters 
 
112 | P a g e  
 
Appendix I: Expense Report 
 
Biomedical Engineering Department 
Item Description Item Quantity Price Purchase Date Receipt/Purchase Order 
#17 O-Ring 1 Pack $1.97 11/18/2006 
#14 O-Ring 1 Pack $1.97 11/18/2006 
#18 O-Ring 1 Pack $1.97 11/18/2006 
  
T6511 3-1/2" Diameter, 1/4" 
Length Aluminum Rod 4 $16.80 12/18/2006   
Brushless DC Motor 36VDC & 
1000 Line Differential Encoder w/ 
Index 
1 $107.37 12/21/2007   
Tygon Tubing 1" ID 12.20FT $79.91 CH-01/30/2007 
Glycerine 7.50L $270.90 CH-01/30/2007 
  
1/2" ID Tygon Tubing 10FT $33.50 CH-02/01/2007 
1L Squeeze Bottle 1 $5.78 CH-02/01/2007 
3/4" Tygon Tubing 1FT $3.35 CH-02/01/2007 
Nitrile Latex Gloves 1 Box $10.00 CH-02/01/2007 
  
5GAL Bucket Lid 1 $1.38 2/9/2007   
330GPH Direct Drive Pump 1 $49.97 2/9/2007   
Sliding Drawer 1 $6.48 2/17/2007   
80" Upright Brackets 2 $19.94 2/20/2007   
Sheet Metal 2 $12.88 2/20/2007   
  TOTAL: $624.17 
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Mechanical Engineering Department 
Item Description Item Quantity Price Purchase Date Receipt/Purchase Order 
BSL Pressure Transducer 2 $490.00 11/6/2006 
 
BK Precision Power Supply 1 $229.00 11/22/2006 
 
1x12x4 No.2 Wood 1 $10.50 1/16/2007   
2x4-96 Stud Wood 1 $2.07 1/17/2007 
1" Corner Brace 1 Pack $1.89 1/17/2007 
  
Mold Builder 1 Pint $12.24 1/23/2007   
Mold Builder 1 Pint $12.99 1/25/2007   
Mold Builder 1 Pint $12.99 1/28/2007   
Polyurethane Glue 1 $6.97 1/29/2007 
Vinyl Tubing 4FT $3.49 1/29/2007 
  
Teflon Tape 1 Roll $0.70 CH-02/01/2007 
Ethanol 1L $3.10 CH-02/01/2007 
1L Plastic Bottle 1 $3.90 CH-02/01/2007 
  
Quick Plastic 1 $2.97 2/5/2007 
5GAL Bucket Lid 1 $1.99 2/5/2007 
3/4 F Adapter 1 $0.64 2/5/2007 
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3/4 M Adapter 1 $0.50 2/5/2007 
1/2 M Adapter 1 $0.21 2/5/2007 
PVC Bushing 1 $0.45 2/5/2007 
PVC Ball Valve 1 $5.41 2/5/2007 
1 1/4" PVC Ball Valve 1 $5.93 2/9/2007 
1/4" Adapter 2 $2.72 2/9/2007 
5GAL Bucket 1 $4.98 2/9/2007 
  
1x6x6 Pine Wood 1 $4.29 2/17/2007 
Aquamend 2 $5.94 2/17/2007 
  
1-1/12 Angle Brackets 4 $1.56 2/20/2007 
Screws 1 Bag $0.98 2/20/2007 
Screws 1 Bag $0.98 2/20/2007 
Contact Cement 30 OZ $3.19 2/20/2007 
  
Sheet Metal 1 $6.66 2/21/2007 
1-1/2 Angle Bracket 2 $0.78 2/21/2007 
  
1x1/2 Slip Joint 2 $5.06 2/23/2007 
Nylon Barb 1 $2.13 2/23/2007 
  
6', 1-1/4" Outer, 1" Inner 1 $9.64 2/23/2007   
Aquamend 1 $2.97 3/3/2007   
Aquamend 3 $8.91 3/5/2007   
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1x10 PVC 1 $2.90 3/5/2007   
  TOTAL: $871.63 
 
